var title_f40_41_41616="Microhyphema";
var content_f40_41_41616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Microhyphema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyphemas. This 7-year-old girl was struck by a hard rubber ball and presented with blurred vision. The 1-mm hyphema (arrow) was only visible when she was upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Trauma: Head and Neck. In: Atlas of Pediatric Emergency Medicine. Fleisher GR, Ludwig S, Baskin MN (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41616=[""].join("\n");
var outline_f40_41_41616=null;
var title_f40_41_41617="Hydrogen peroxide: Pediatric drug information";
var content_f40_41_41617=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hydrogen peroxide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1047713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibacterial, Otic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibacterial, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Oral Rinse",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1047710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mouthwash or gargle: Dilute the 3% solution with an equal volume of water; swish around in the mouth over the affected area for at least 1 minute and then expel; use up to 4 times/day (after meals and at bedtime)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.5% to 3% solution for cleansing wounds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.5% gel for cleansing wounds or mouth/gum irritations: Apply a small amount to the affected area for at least 1 minute, then expectorate; use up to 4 times/day (after meals and at bedtime)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F243234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, oral: 1.5% (15 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Concentrate: 30.5% (480 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Topical: 3% (120 mL, 480 mL)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1047716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical: Do not inject or instill into closed body cavities from which released oxygen cannot escape; strong solutions (30.5%) of hydrogen peroxide should not be applied undiluted to tissues",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1047712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Protect from light and heat; decomposes upon standing, upon repeated agitation, or when in contact with oxidizing or reducing substances",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1047715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cleanse wounds, suppurating ulcers, and local infections; used in the treatment of inflammatory conditions of the external auditory canal and as a mouthwash or gargle; hydrogen peroxide concentrate (30%) has been used as a hair bleach and as a tooth bleaching agent",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F14198747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Bleaching effect on hair, irritating burn",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Rupture of the colon, proctitis, ulcerative colitis, gas embolism, hairy tongue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Irritation of the buccal mucous membrane",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1047719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should not be used in abscesses",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1047709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Repeat use as a mouthwash or gargle may produce irritation of the buccal mucous membrane or &ldquo;hairy tongue&rdquo;; bandages should not be applied too quickly after its use",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1047708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hydrogen peroxide concentrate (30%) is a caustic liquid; it should not be tasted since it is strongly irritating to skin or mucous membranes",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1047707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antiseptic oxidant that slowly releases oxygen and water upon contact with serum or tissue catalase",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1047718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration: Only while bubbling action occurs",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13362 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-217.16.9.173-E29AE5AA73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41617=[""].join("\n");
var outline_f40_41_41617=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047713\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047710\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F243234\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047716\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047712\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047715\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14198747\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047719\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047709\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047708\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047707\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047718\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13362\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13362|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41618="Measles pneumonia light microscopy";
var content_f40_41_41618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54083&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Measles pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a lung biopsy from a patient with measles pneumonia shows a nodular pattern with acute and chronic inflammation and areas of necrosis and fibrosis. Multinucleated giant cells with inclusions (arrows) are also shown (hematoxylin-eosin, 500X).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Angel, JB, Walpita, P, Lerch, RA, et al, Ann Intern Med 1998; 129:104.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41618=[""].join("\n");
var outline_f40_41_41618=null;
var title_f40_41_41619="Sacrosidase: Drug information";
var content_f40_41_41619=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sacrosidase: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/27/9652?source=see_link\">",
"    see \"Sacrosidase: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/12/16579?source=see_link\">",
"    see \"Sacrosidase: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F219729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sucraid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F219730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sucraid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F219742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Enzyme, Gastrointestinal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F219732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Congenital sucrase-isomaltase deficiency (CSID):",
"     </b>",
"     Oral: 17,000 units (2 mL) per meal or snack. Doses should be diluted with 2-4 oz of cold or room temperature water, milk, or formula. Approximately one-half of the dose should be taken before and the remainder of a dose taken during each meal or snack.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F219737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/12/16579?source=see_link\">",
"      see \"Sacrosidase: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Congenital sucrase-isomaltase deficiency (CSID):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants &ge;5 months and Children &le;15 kg: Oral: 8500 units (1 mL) per meal or snack. Doses should be diluted with 2-4 oz of cold or room temperature water, milk, or formula. Approximately one-half of the dose should be taken before and the remainder of a dose taken during each meal or snack.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &gt;15 kg and Adolescents: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F219733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F219712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sucraid&reg;: 8500 units/mL (118 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F219698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11234325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sucraid&reg; is not available in retail pharmacies or via mail-order pharmacies. To obtain the product, please refer to file://www.sucraid.net/how-to-order-sucraid or call 1-866-740-2743.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F219714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dilute dose in 2-4 oz of cold or room temperature water, milk, or formula; avoid fruit juices or warm or hot food/liquids (may lower potency).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F219713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral replacement therapy in sucrase deficiency, as seen in congenital sucrase-isomaltase deficiency (CSID)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F219740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache, insomnia, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Hypersensitivity reactions, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F219717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to yeast, yeast products, glycerin (glycerol), or papain",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F219702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Hypersensitivity reactions to sacrosidase, including bronchospasm, have been reported. Administer initial doses in a setting where acute hypersensitivity reactions may be treated within a few minutes. Skin testing for hypersensitivity may be performed prior to administration to identify patients at risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes mellitus: Use with caution in patients with diabetes; sacrosidase enables absorption of fructose and glucose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Papain: Product may contain papain. Severe hypersensitivity reactions, including anaphylaxis, have been observed with papain exposure. Tachycardia and hypotension, in association with some papain-induced hypersensitivity reactions, has also been observed. In addition, inconclusive data suggests a possible cross-sensitivity may exist between patients with natural rubber latex hypersensitivity and papaya, the source of papain.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F219707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F219727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: May be inactivated or denatured if administered with fruit juice or warm or hot food/liquids. Isomaltase deficiency is not addressed by supplementation of sacrosidase. Management: Administer with 2-4 oz of water, milk, or formula. Because isomaltase deficiency is not addressed by supplementation of sacrosidase, adherence to a low-starch diet may be required.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F219709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F219721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Should be administered to a pregnant woman only when indicated.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F219735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/compatible",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F9614165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not take with fruit juices. Because isomaltase deficiency is not addressed by supplementation of sacrosidase, adherence to a low-starch diet may be required.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F219720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Sucraid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8500 units/mL (118 mL): $3759.60",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6875321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Sucraid (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F219701\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sacrosidase is a naturally-occurring gastrointestinal enzyme derived from baker&rsquo;s yeast (",
"     <i>",
"      Saccharomyces cerevisiae",
"     </i>",
"     ) which breaks down the disaccharide sucrose to its monosaccharide components. Hydrolysis is necessary to allow absorption of these nutrients.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F219716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Amino acids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: GI tract to individual amino acids",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Blanco C, Carrillo T, Castillo R, et al, &ldquo;Latex Allergy: Clinical Features and Cross-Reactivity With Fruits,&rdquo;",
"      <i>",
"       Ann Allergy",
"      </i>",
"      , 1994, 73(4):309-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41619/abstract-text/7943998/pubmed\" id=\"7943998\" target=\"_blank\">",
"        7943998",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Focke M, Hemmer W, Wohrl S, et al, &ldquo;Cross-reactivity Between",
"      <i>",
"       Ficus benjamina",
"      </i>",
"      Latex and Fig Fruit in Patients With Clinical Fig Allergy,&rdquo;",
"      <i>",
"       Clin Exp Allergy",
"      </i>",
"      , 2003, 33(7):971-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41619/abstract-text/12859455/pubmed\" id=\"12859455\" target=\"_blank\">",
"        12859455",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Freye HB, &ldquo;Papain Anaphylaxis: A Case Report,&rdquo;",
"      <i>",
"       Allergy Proc",
"      </i>",
"      , 1988, 9(5):571-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41619/abstract-text/3234762/pubmed\" id=\"3234762\" target=\"_blank\">",
"        3234762",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Isola S, Ricciardi L, Saitta S, et al, &ldquo;Latex Allergy and Fruit Cross-Reaction in Subjects Who Are Nonatopic,&rdquo;",
"      <i>",
"       Allergy Asthma Proc",
"      </i>",
"      , 2003, 24(3):193-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41619/abstract-text/12866323/pubmed\" id=\"12866323\" target=\"_blank\">",
"        12866323",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Treem WR, McAdams L, Stanford L, et al, &ldquo;Sacrosidase Therapy for Congenital Sucrose-Isomaltase Deficiency,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1999, 28(2):137-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41619/abstract-text/9932843/pubmed\" id=\"9932843\" target=\"_blank\">",
"        9932843",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10253 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-13CD9D8202-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41619=[""].join("\n");
var outline_f40_41_41619=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219729\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219730\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219742\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219732\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219737\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219733\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219712\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219698\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234325\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219714\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219713\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219740\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219717\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219702\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300019\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219707\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219727\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219709\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219721\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219735\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9614165\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219720\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6875321\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219701\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219716\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10253\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10253|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/27/9652?source=related_link\">",
"      Sacrosidase: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/12/16579?source=related_link\">",
"      Sacrosidase: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41620="Alfentanil: Patient drug information";
var content_f40_41_41620=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alfentanil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/9/3223?source=see_link\">",
"     see \"Alfentanil: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/53/2903?source=see_link\">",
"     see \"Alfentanil: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alfenta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alfentanil Injection, USP;",
"     </li>",
"     <li>",
"      Alfenta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F13258570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put you to sleep for surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701459",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alfentanil or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698063",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694370",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A shot may be given into the spinal fluid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11283 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-CCB85E928E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41620=[""].join("\n");
var outline_f40_41_41620=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131467\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131468\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13258570\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015286\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015285\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015289\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015290\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015292\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015288\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015293\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015294\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/9/3223?source=related_link\">",
"      Alfentanil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/53/2903?source=related_link\">",
"      Alfentanil: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41621="MAI duodenum Light";
var content_f40_41_41621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    MAI infection in the duodenum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of duodenal biopsy in an HIV-infected patient with Mycobacterium intracellulare infection in the duodenum. There are numerous lamina propria macrophages containing Mycobacteria which are best seen with an acid-fast stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41621=[""].join("\n");
var outline_f40_41_41621=null;
var title_f40_41_41622="Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis";
var content_f40_41_41622=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     A Oliver Sartor, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Steven J DiBiase, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41622/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/41/41622/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of clinical manifestations of prostate cancer has changed substantially since the introduction of prostate specific antigen (PSA) screening with a higher percentage of men now having localized disease at presentation. However, metastatic prostate cancer remains an important clinical problem, both in terms of the number of affected men and its impact on quality of life.",
"   </p>",
"   <p>",
"    The bones of the axial skeleton are the predominant site of metastasis in most men with metastatic prostate cancer (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83138 \" href=\"mobipreview.htm?42/33/43542\">",
"     image 1",
"    </a>",
"    ), and these lesions can cause pain, debility,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    functional impairment. The clinical manifestations and diagnostic assessment of bone metastases in men with prostate cancer are reviewed here. The management of prostate cancer bone metastases is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/36999?source=see_link\">",
"     \"Management of bone metastases in advanced prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant cells are widely disseminated in men with advanced prostate cancer. However, metastases preferentially develop in the bones of the axial skeleton, where red marrow is most abundant. The reasons for this pattern of metastasis are unclear but the leading hypothesis focuses on symbiotic interactions between prostate cancer cells and bone stromal cells such as osteoblasts, osteoclasts, and fibroblasts.",
"   </p>",
"   <p>",
"    The bone metastases in men with prostate cancer are usually osteoblastic (ie, characterized by new bone formation). However, increases in bone resorption have been consistently demonstrated histologically and biochemically. Bone destruction is an important factor in the etiology of pain and other complications due to bone metastases, although it is unclear if such bone destruction precedes the development of osteoblastic metastases or is a consequence of increased bone formation.",
"   </p>",
"   <p>",
"    The mechanisms by which prostate cancer tumor cells induce osteoblastic changes are unclear, but are thought to involve excess activation of osteoblast mitogens, some of which are derived from bone stroma (insulin-like growth factors, transforming growth factor-beta, bone-morphogenic proteins, proteases, fibroblast growth factors, endothelin, other soluble factors) and others from the prostate cancer itself. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31737?source=see_link&amp;anchor=H16#H16\">",
"     \"Mechanisms of bone metastases\", section on 'Osteoblastic metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19253279\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone is the predominant site of disseminated prostate cancer in men who present with or subsequently develop metastatic disease. Although bone metastases are often asymptomatic initially, patients can eventually develop complications that require treatment; these skeletal-related complications include pain requiring irradiation, pathologic fractures, spinal cord compression, surgery to bone, and occasionally abnormalities of calcium metabolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H102891787\">",
"    <span class=\"h2\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain is the most common manifestation of bone metastases. Pain from bone metastases is typically insidious in onset and slowly increases in severity over weeks to months. However, there are exceptions, such as a pathologic fracture or the sudden onset of back pain that accompanies the collapse of a cancer-containing vertebral body.",
"   </p>",
"   <p>",
"    Although bone pain due to metastasis is commonly described as aching (like a toothache), nerve root entrapment, a common complication associated with vertebral metastases, may cause a burning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiating type of pain.",
"   </p>",
"   <p>",
"    Pain located distal to the knees or elbows is less likely to be malignant than that located proximally or centrally because cancers typically spread to bone areas with active marrow function. Arthritic pain is more likely to localize to joints than pain from bone metastases, but history alone cannot reliably distinguish the two. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7077?source=see_link\">",
"     \"Assessment of cancer pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uncontrolled pain due to bone metastases results in unnecessary suffering, decreased ability to cope with illness, interference with activities of daily living, and can necessitate extended or repeat hospital admissions. Uncontrolled pain may also delay or disrupt anticancer treatment, compromising its effectiveness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/36999?source=see_link\">",
"     \"Management of bone metastases in advanced prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43704?source=see_link\">",
"     \"Cancer pain management: General principles and risk management for patients receiving opioids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H102891801\">",
"    <span class=\"h2\">",
"     Pathologic fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic fractures are an important but relatively uncommon clinical manifestation of bone metastases from prostate cancer (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83214 \" href=\"mobipreview.htm?25/24/25987\">",
"     image 2",
"    </a>",
"    ). Although prostate cancer bone metastases are typically osteoblastic, the structure of osteoblastic bone may be abnormal and there is usually a significant destruction of normal bone cortex.",
"   </p>",
"   <p>",
"    Systemic treatment with androgen deprivation therapy (ADT) can contribute to osteoporosis, which increases the risk of fractures. Osteoporotic fractures need to be distinguished from those pathologic fractures caused by bone metastasis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31737?source=see_link&amp;anchor=H19#H19\">",
"     \"Mechanisms of bone metastases\", section on 'Prostate cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21993?source=see_link&amp;anchor=H7#H7\">",
"     \"Side effects of androgen deprivation therapy\", section on 'Osteoporosis and bone fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H102891809\">",
"    <span class=\"h2\">",
"     Spinal cord compression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral metastases are a particularly common site of metastatic disease in men with advanced prostate cancer. Such metastases can cause spinal cord compression and severe neurologic deficits.",
"   </p>",
"   <p>",
"    Pain is usually the first symptom of spinal cord compression, and this generally precedes the development of other symptoms by weeks or even months. A focused neurologic examination is required in men with back pain because of the risk of epidural spinal cord compression. Symptoms occurring later can include motor weakness, sensory findings, bowel and bladder dysfunction, and ataxia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6585?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early recognition of the clinical features of epidural spinal cord compression followed by prompt treatment is critical in minimizing the neurologic deficits associated with this complication. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26970?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment and prognosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Primary treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H102891824\">",
"    <span class=\"h2\">",
"     Hypercalcemia and hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypercalcemia is relatively uncommon in men with advanced prostate cancer compared with other malignancies where osteolytic disease is more common than osteoblastic disease. Hypocalcemia is more frequent, but is generally asymptomatic. Hypocalcemia may also be due to treatment with bone modifying agents (bisphosphonates,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41734?source=see_link\">",
"     \"Hypercalcemia of malignancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/43/39610?source=see_link&amp;anchor=H1930509#H1930509\">",
"     \"Risks of therapy with bone modifying agents in patients with advanced malignancy\", section on 'Hypocalcemia and other electrolyte abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732975\">",
"    <span class=\"h2\">",
"     Other laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common abnormal laboratory findings observed in men with bone metastatic prostate cancer are a rising serum PSA level, an elevation in serum alkaline phosphatase, and anemia. However, these laboratory abnormalities are not useful in either establishing or ruling out the diagnosis of bone metastasis in men with prostate cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum PSA is typically &gt;10",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      in men with metastatic well-differentiated or moderately differentiated tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/1\">",
"       1",
"      </a>",
"      ]. However, some prostate cancers produce little PSA, and lower or even normal PSA values do not exclude bone metastases. Knowledge of serum testosterone is very helpful in interpreting PSA levels. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/8/6280?source=see_link&amp;anchor=H19#H19\">",
"       \"Chemotherapy in castrate-resistant prostate cancer\", section on 'Prostate cancer with low PSA production'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Osteoblastic metastases are commonly but not inevitably accompanied by elevations in markers of bone turnover (eg, serum bone-specific alkaline phosphatase, urinary hydroxyproline, urinary deoxypyridinoline). However, these are not routinely measured clinically. Although serial measurement of biochemical bone markers may not be useful in men with metastatic prostate cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/2,3\">",
"       2,3",
"      </a>",
"      ], a significant decline in bone-derived alkaline phosphatase is a reasonably reliable indicator of a favorable therapeutic response. In addition, high levels of bone-associated alkaline phosphatase are associated with a greater risk of adverse skeletal outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/2,4,5\">",
"       2,4,5",
"      </a>",
"      ]. Because elevated serum alkaline phosphatase can be derived from bone or liver, further evaluation to distinguish the site of origin may be warranted. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/33/42519?source=see_link\">",
"       \"Bone physiology and biochemical markers of bone turnover\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"       \"Approach to the patient with abnormal liver biochemical and function tests\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anemia is common and typically is proportional to the extent of bone involvement. However, anemia may also be caused by a variety of factors including androgen deprivation therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/6\">",
"       6",
"      </a>",
"      ], systemic cytotoxic chemotherapy, disseminated intravascular coagulation, or a combination of poorly defined tumor-related factors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538652437\">",
"    <span class=\"h2\">",
"     Frequency of skeletal-related events",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of progression to metastatic disease at presentation, and hence the risk of subsequently developing bone metastases, is a function of multiple factors, which are incorporated into the American Joint Committee on Cancer (AJCC) staging system. In a prospective study looking at risk of future bone metastases, the most important factor for men with castrate resistant prostate cancer and non-metastatic disease was a rapidly rising PSA and a baseline PSA of &gt;13.0",
"    <span class=\"nowrap\">",
"     ng/ml",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/30/9704?source=see_link\">",
"     \"Prostate cancer: Risk stratification, other prognostic factors, and predictive tools\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The frequency of skeletal-related complications rises progressively with more extensive disease. The incidence of such events in men with castrate resistant prostate cancer who have developed bone metastases was illustrated by a trial in which 1901 patients were randomly assigned to osteoclast inhibition with either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/53/21335?source=see_link\">",
"     denosumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/8\">",
"     8",
"    </a>",
"    ]. The median times to first skeletal-related event were 17 and 21 months, respectively. For the entire cohort, the frequencies of bone pain requiring radiation therapy, pathologic fracture, and spinal cord compression were 20, 15, and 3 percent, respectively. In these studies pathologic fracture rates were assessed by skeletal surveys rather than symptoms. In more recent studies that used symptoms rather than skeletal surveys to detect pathologic fractures, the risk of pathologic fracture was 7 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538652451\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain is the most common manifestation of bone metastases. Prostate cancer patients with bone pain that cannot be definitively attributed to another condition should be evaluated for bone metastases. Pathologic fracture and spinal cord compression are less common and usually occur in the context of a patient with known bone metastases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5198021\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine evaluation for occult bone metastases in asymptomatic patients is not indicated in many cases at initial diagnosis or at the first evidence of a rising PSA following definitive therapy because of the low incidence of metastatic disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In multiple clinical trials involving non-metastatic castrate resistant prostate cancer patients, the risk of metastases is proportional to both the PSA value and the rate of PSA rise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41622/abstract/7,10\">",
"       7,10",
"      </a>",
"      ]. Exact PSA values associated with bone-metastatic castrate resistant prostate cancer are variable but in these studies PSA values of less than 10",
"      <span class=\"nowrap\">",
"       ng/ml",
"      </span>",
"      were not typically associated with metastatic disease.",
"     </li>",
"     <li>",
"      In newly diagnosed patients with prostate cancer, evaluation of bone metastases should be limited to those who are at increased risk for the development of metastases, based upon clinical stage, Gleason score,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      serum PSA level. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=see_link&amp;anchor=H686719772#H686719772\">",
"       \"Initial staging and evaluation of men with newly diagnosed prostate cancer\", section on 'Staging evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The evaluation of asymptomatic patients who have previously received definitive treatment for prostate cancer and then have a rising serum PSA is discussed separately. Risk factors for disseminated disease at the original presentation along with prognostic factors such as the recurrence-free interval and the PSA doubling time are all factors that need to be considered in determining whether or not to evaluate for bone metastases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/31/20983?source=see_link\">",
"       \"Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5198181\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development or worsening of bone pain is the primary indication for evaluation for bone metastases but should not automatically be interpreted as due to bone metastasis. Worsening pain from a wide range of nonmalignant conditions (eg, arthritis, disc injury, musculoskeletal discomfort related to physical exertion) and treatment-related complications (eg, nerve root compression from vertebral body collapse due to treatment-related osteoporosis) need to be considered in the differential diagnosis.",
"   </p>",
"   <p>",
"    The choice of imaging procedure is guided by the clinical setting:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Radionuclide bone scan",
"      </strong>",
"      &ndash; Technecium-99 (99Tc)-MDP radionuclide bone scans are typically used as the first test for the evaluation of a patient with suspected bone metastases, but without symptoms or physical findings suggesting a pathologic fracture or incipient spinal cord compression. Bone scans are particularly sensitive for the detection of osteoblastic metastases and are the most useful imaging modality to assess the presence, number, and anatomic distribution of bone metastases in men with prostate cancer (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef83139 \" href=\"mobipreview.htm?15/18/15655\">",
"       image 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=see_link&amp;anchor=H686719821#H686719821\">",
"       \"Initial staging and evaluation of men with newly diagnosed prostate cancer\", section on 'Radionuclide bone scan'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Bone scans are most effective in detecting osteoblastic metastases and those with mixed blastic and lytic components. Occasional patients have predominantly osteolytic disease, and a negative bone scan does not rule out bone metastases. Plain radiography or MRI is indicated if bone metastases are suspected following a negative bone scan.",
"     </li>",
"     <li>",
"      <strong>",
"       Plain radiographs",
"      </strong>",
"      &ndash; Plain radiographs are more specific but less sensitive than bone scans. Plain films are the preferred initial imaging procedure when a pathologic fracture or compression fracture is suspected.",
"      <br/>",
"      <br/>",
"      Benign lesions can cause increased uptake on a bone scan, and plain radiographic imaging may also be indicated to confirm abnormal or equivocal findings from a radionuclide bone scan. Plain films may also be useful for diagnosing treatment-related osteoporosis and osteoporotic fractures.",
"     </li>",
"     <li>",
"      <strong>",
"       Magnetic resonance imaging",
"      </strong>",
"      &ndash; Urgent magnetic resonance imaging (MRI) is indicated for patients with a suspected spinal cord compression based upon symptoms or physical findings. (See",
"      <a class=\"local\" href=\"#H102891809\">",
"       'Spinal cord compression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6585?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Radiologic confirmation'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In preliminary studies, MRI of the axial skeleton may be more sensitive than a radionuclide bone scan for the detection of occult metastases. However, these findings need to be confirmed. The cost of MRI and availability considerations has limited the use of MRI as the initial imaging procedure when bone metastases are suspected. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=see_link&amp;anchor=H686719842#H686719842\">",
"       \"Initial staging and evaluation of men with newly diagnosed prostate cancer\", section on 'Axial skeleton MRI'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Positron emission tomography (PET) using 18-fluoro-2-deoxyglucose (FDG) is not been a reliable technique for the detection of metastatic prostate cancer because of limited glucose uptake by prostate cancer cells. However, 18-flouride scintigraphy, PET, or PET CT are highly sensitive in detecting bone metastases and this isotope has been increasingly substituted for 99-Tc-MDP scans when the conventional isotope was not available. Other, tracers are under development and may ultimately prove to be more sensitive for use in men with prostate cancer. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=see_link&amp;anchor=H686719852#H686719852\">",
"       \"Initial staging and evaluation of men with newly diagnosed prostate cancer\", section on 'PET'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bone is the predominant site of disseminated disease in men with prostate cancer who present with or subsequently develop metastatic disease. Pain is the most common manifestation of bone metastases. Pain from bone metastases is typically insidious in onset and slowly increases in severity over weeks to months. (See",
"      <a class=\"local\" href=\"#H102891787\">",
"       'Pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pathologic fractures are an important clinical manifestation of bone metastases from prostate cancer. Although prostate cancer bone metastases are typically osteoblastic, the structure of osteoblastic bone may be abnormal and there is often a significant osteolytic component. (See",
"      <a class=\"local\" href=\"#H102891801\">",
"       'Pathologic fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vertebral metastases are a particularly common site of metastatic disease in men with advanced prostate cancer. Such metastases can cause spinal cord compression and severe neurologic deficits. Early recognition of the clinical features of epidural spinal cord compression followed by prompt treatment is the most important step in minimizing the neurologic deficits associated with this complication. (See",
"      <a class=\"local\" href=\"#H102891809\">",
"       'Spinal cord compression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26970?source=see_link&amp;anchor=H2#H2\">",
"       \"Treatment and prognosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Primary treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of bone metastases is based upon imaging findings. The choice of imaging procedure is based upon the clinical setting :",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Routine imaging is not indicated in patients at low risk for the development of bone metastases. (See",
"      <a class=\"local\" href=\"#H5198021\">",
"       'Asymptomatic patients'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=see_link&amp;anchor=H686719772#H686719772\">",
"       \"Initial staging and evaluation of men with newly diagnosed prostate cancer\", section on 'Staging evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/31/20983?source=see_link\">",
"       \"Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Technecium-99 (99-Tc) MDP radionuclide bone can is the current preferred imaging modality for the overall assessment of the number and location of bone metastases. (See",
"      <a class=\"local\" href=\"#H102891787\">",
"       'Pain'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5198181\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs are particularly useful for the initial assessment of patients thought to have a pathologic fracture. They are also indicated for the assessment of equivocal findings on bone scan and for patients with purely osteolytic disease. (See",
"      <a class=\"local\" href=\"#H102891801\">",
"       'Pathologic fractures'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5198181\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI) is required for prompt evaluation of patients having signs or symptoms suggestive of spinal cord compression. (See",
"      <a class=\"local\" href=\"#H102891809\">",
"       'Spinal cord compression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6585?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Radiologic confirmation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/1\">",
"      Gleave ME, Coupland D, Drachenberg D, et al. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996; 47:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/2\">",
"      Smith MR, Cook RJ, Coleman R, et al. Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer. Urology 2007; 70:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/3\">",
"      Hopkins SC, Nissenkorn I, Palmieri GM, et al. Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. J Urol 1983; 129:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/4\">",
"      Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002; 94:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/5\">",
"      Noguchi M, Yahara J, Noda S. Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer. Urology 2003; 61:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/6\">",
"      Bogdanos J, Karamanolakis D, Milathianakis C, et al. Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement. Anticancer Res 2003; 23:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/7\">",
"      Smith MR, Cook R, Lee KA, Nelson JB. Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer. Cancer 2011; 117:2077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/8\">",
"      Fizazi K, Carducci M, Smith M, et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 2011; 377:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/9\">",
"      Sartor AO. Guidelines. American Society of Clinical Oncology 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41622/abstract/10\">",
"      Smith MR, Kabbinavar F, Saad F, et al. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J Clin Oncol 2005; 23:2918.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6948 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41622=[""].join("\n");
var outline_f40_41_41622=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19253279\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H102891787\">",
"      Pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H102891801\">",
"      Pathologic fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H102891809\">",
"      Spinal cord compression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H102891824\">",
"      Hypercalcemia and hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1732975\">",
"      Other laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H538652437\">",
"      Frequency of skeletal-related events",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H538652451\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5198021\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5198181\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/6948\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/6948|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?42/33/43542\" title=\"diagnostic image 1\">",
"      Diffuse osteoblastic metastases in prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?25/24/25987\" title=\"diagnostic image 2\">",
"      Pathological fracture in metastatic prostate carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/18/15655\" title=\"diagnostic image 3\">",
"      Osteoblastic metastases to the lumbar spine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7077?source=related_link\">",
"      Assessment of cancer pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/33/42519?source=related_link\">",
"      Bone physiology and biochemical markers of bone turnover",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43704?source=related_link\">",
"      Cancer pain management: General principles and risk management for patients receiving opioids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/8/6280?source=related_link\">",
"      Chemotherapy in castrate-resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6585?source=related_link\">",
"      Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41734?source=related_link\">",
"      Hypercalcemia of malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/62/23527?source=related_link\">",
"      Initial staging and evaluation of men with newly diagnosed prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/36999?source=related_link\">",
"      Management of bone metastases in advanced prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31737?source=related_link\">",
"      Mechanisms of bone metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/30/9704?source=related_link\">",
"      Prostate cancer: Risk stratification, other prognostic factors, and predictive tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/31/20983?source=related_link\">",
"      Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/43/39610?source=related_link\">",
"      Risks of therapy with bone modifying agents in patients with advanced malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21993?source=related_link\">",
"      Side effects of androgen deprivation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26970?source=related_link\">",
"      Treatment and prognosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41623="Diffuse alopecia in SS";
var content_f40_41_41623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83374%7EHEME%2F83373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83374%7EHEME%2F83373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diffuse alopecia in S&eacute;zary syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 306px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEyASADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6GWTeeKfVGxk3jODV6qICiiigBcZo2j3pPxo59aBjttJnFGc8ZrH1nVY7CFzvHmY+U+9Q9B2bJdY1e10tS1wQ7kcCvMte1u51KcsRtjB4X2qrq9/cX160szb0HYVUUry+ST2HpUuZ6FCg17w3ZukPy4JqwFEYyetR+bvdWOAFFMSdWk2uCR61zzdz0KcC7Ec/PUqzyF/m+7VONmLlU6VYBYgqRzXO2bqHUtKSfuODTXDqQw+9UUUHljcCR3qYSEjgZqLjaJARgE9aeJN4PXjtUcX3SWU5pftBjiKhRk1aYrE6tsUfJjPelK5GRUBLyIvOMVPb8jBqrhYrzB2wVPTtTQxY5lXirRA3k4xUUpIQjg0XLSHSWZaDekYKetV4tyhlPTtT1mlZNhY+X/dFN8s7SyE8djTTFYYHAfbL0pzYY4BqCXMoxtIao13xsGJyPSnLULE4Y28itGxVwcgg8iul0XxZMkoh1Bw6HgSEc/jXNqgml5cKMdTULREs21h8v61rRqOO5zYihGtuewWtzHcRh4mDAjPFTV5l4X1hrScI7kRHjB7GvSLWZZ4ldehFdkZKWx4Vai6UrMlooopmQUUUUAFBoooAxdDufMStoZxXN+H4yic10KHjrSFcfRSUE0Degp6U3NJnmsvxBq8el2zFsGZhgKO1JysOOpF4k1yPS7cxx/NcOOnpXmeo6hLcufNcsT29KNav3kZpJGLSP3J5FY4ym07ixbqT2qJM7qFLqyS5LR4w3B7VDFKTKBjFOJZEZmG/0z2ptuWJDFeM1zyZ6dNaEpJLkA1YgUsvG3NVw6h3x1PSrKRtL5YUbPXFZNnVGNiaJmQjpnvirtl+83lhUC+WibSfmFWIJQEOABWMmU9di0NvlndUCDadwHy1G8uU4OeaWSfCqrDAPpUbkqLJvM3n5RxTWG5+lBQrECpxTlZT3qkPlHtJ5WMLk+lNWdywPl7RTNqiRWDMWHQU95d3DnFUCiTyPwAeuKgMgX73SkXA6NuHqaAI93zng07F2sNXlsp92pCu3kHANLuSFsR8rTJ5BIozwfQU0hWKlx8jbt/FOA53diKTeGdkdARVflj94hR2qrisPJYEKpGc559KlldB8zdMYOKoyks3B6U0MRhSSc00xumiXdGu4gEYP5113hHX/JkS2uX+VuEJ/lXLfZ2eL7rEdzUIA2MsbAspBB71vCTizixFKNWPK9z29SGUEcg0tcl4M15bmMWVw/79fuknqK6011p3Pn5wcHZhRRRQSFFFFAGNphUJxWrGeK5zSJty10EZ+UGkSiamNwfrSk8VFIyYLOcKozQXa5X1K+jsLV5pGwQOB715bquoSXl288z5OeBmrnjHWGvr8hGIhj4IHeuUuLhAWIyRUM6qNO5LqjhpYkVgS9VmzGwHUE4J9KqwSmWNjIvzKflNaP7l1TDduawlI9GnDQfGrmEqACKYj8FAMZ4/GmPMIfunIpofzkLdCK55SOulElji2tuJHy9asQ3R8zp2qjGSPvHrU8Migcc1i5HWo6F6IKiMz8lulNlcshCnFVllO/k8U/eC3B4qJSNIxVieOQiIe1TC6CSLuUMCMVWBTyG45zSQ7fMGQTUxYSirF6MSNLukY7T0AqVFO8jBJqLzC2NvGKnikaM5xuLVqjEczMo+VRu7UzCynD5z7VY8shgw5J7VPDbKrAgEs3atEg5lEom1ZXGwkp61YCxsQmRurVOmypEhMgGT92lvtJ2qjYCsfStEjJ1kzOkiRfl/lTJbeP5NpJbrirRtmhX5uapu5EgbstSO7lsR3CqQxUc1V8tCxCHp1FW3ZnjZyvFVVbDBgp3npQUyvPEqE4yCRxmoCmUXH3hV+UCclpCA69qpyYIJB+YdqzcrFRkW49QdYGgjALY+YGq1o0Pksm0h2ztaq6bjNvzt4wTVOKS4BkTOUBzmtlO5E6V9jRs5JbS+guIzh4m5weor2DRNQTULJZkOTjmvHbLmMyNyGrrfh/qLW9zNBKeGI2iumlLozyMbSurno1FAoroPJCiiigDh9NuBDjJrqrGUSxg9a5DS7M3Eakc56V1mnwGGAZoEi5LwODXKeMdW/s+xMef3jmuhuJtuecV5P461QTat1yqDAHrSZtFXZi3F2JZGGcBuTVCYNkBOF70kkiohkIyWPT0qo8zBwd2VPasqjsejQgXxIioc/hT7OTMbI/RuM+lVARLjjC1IZMI6KMgjrXFOZ3RWhYmRBMVj+ZQOKcrb4lCrtbGD71Tt32N8pye9W3fDArjOK53O5tTIZHYHaTyKnVdkSkPzTSgY7m4NPEilFyMCoudUScqGQbTk96WGZAdjLzUQy0itHwv86lyokBKZNVpY0LETHkHkdqu2CFyWOPSqybOrcEirFm+FK9MmktyZPQnmhPmAL0q6keyJPLBJHBqNF7savWKmfcqZ3KfwNaLc5JTsPhsJJt24hcDIXua0bNWs4VM1uzbjjdjpU0MMkrqZV2YHLZ5rQaQRQMA/mAjj2rpSOWpUuMitxKvJLR9QT2qhfK0cgw5dR0FXi7Iibn2xEZ59agfYxOOnrTM4yKLs8owV4rKuoTGW3rgVszM0boU5XuaqX7iUNjBqJG8HqYn2rbC0LLnPSkDSylcRhNo4NOmK/fC5K1WSZmn+RuKi52qN0V7iEJOWZ23HrTRFGzBi5VvWrN25L5IBHrUTQsRnhh1wKlq4tCGRFG5S24t0b1rNkDJLhTgdDWg8eV3dCOgqjIDnPcmqirFJ2J7JmCtGWyg5ArUsJJI71J0baQKzrOFiWdea1YwjIjkhSOCK6Iuxx1ldNHrVhOtzaxSKQdyg1YrjvAmqeeZbVjkJ9z6V2NdkXdHzlSDhKzCilpKZmec+EdSLNscYVa7dZwYC3Y1wun2vkDYgwPXvXSR3I8pQx6DFA0N1q+WG2kbPOK8aupWvNUleQ/LkkV3HjK/McB2kZbivPkJZmYcfWpbsdVKLuR3cnzhR0FVycnOKlLDeVIB96aXI4UD8a5qrvsenRVhcloxt61ZhjOBuPHeoIkZRu9amWUA5auOSOuJEoVJ25OKsQozS5BOKinZfNXaBVyFunAAHpWElY0gSTRMFGKjKnZirWcjg0gCnmoN4uxEjGNQKmXP3utI5jMTf3h0qW1iPlgnqfWr6FcyFSQsMkVoQMGjyBzUAjKjBAxUkTCJeBwalPUTd0XrQO78nity0CBcK4Vu9Ydmdo3E1egdWky/A9RXQtzkqRub9qPP81iWJRemetPhU28S+YcB+maz4A5ZnhlwpGCBWgoSWONZWLBPWuhanLKJMyAxqskgf6U2XDPsQgDFPgCh2DABRytUbgEMZNxBzjimTFDBlJjGxyKp3J8uU+hFTybVdXLE+tV7pwScHI7VMkbw3Md5P3j+lQh0D73G0Hip5AoyO5pJoljCbypzWR3RehE0mwOgXeGHFQRKdrMWIbpikV9lyWzwOMU8t5mXKYwf4apNCkuxWUEybCDu7mq88TKWO4EDtVxnJuDIeFPSoLpEUtIu45600iHLoNiLpHlDT7eZz17Hmqyb0yyc+xqS2dh5juAN/GK1WpnJdzZ8O3TWmuRurYjJ5r2CJg6KyngjNeHxq23Med4INeu+Grj7RpUDg5IXDV0U5dDxcdCzubD4KA984qOjqKYcoDjmtjzjjooPO5UgUlyDFGc8kVWsJnVvmGKXU7kCMtnp1oKitTh/FN0Jr5Yc5Xv7Vz904jOw9D6Vfv5FlvZmXoTWHeNmbI7cVEjvpIasmJ9uMpU0o+ZcVXtztR3b1qckNhh0Fcsz0KSLDBlXB7UqIHGPWmQsZdwJ+bvSJJhticbTya52jqSH3UPllcc0sFxtJRuuadK+HUjnNNkZd+Nnzdc1jJaGsUXkbpzjPari7enesq2lVZNzru9KtRzFW3leazsXYuJAuSSKsTjai7eo7VXW583aAMMTVyNmFwUwpcjvVp6WJdyN5CI+vNELiWLHcHNSxxKk7eaB0qms/7yQIuMdKSjrcavY1YFYgN2FX7cq4weKzIJ2W3BIq3FIGWNl6nrWsSJLQ1bcrCNwJ47Vdhbnk43+tZryqIxk80G6V2Ve4rZOxyyhc32fKcdQMVXcrKm0kCqCzv1J9qSRwEOepp3IjTZPciJMJndu7is+7AiICngdTU3mKI+etUdUuAtt8p69aJM6YQKVy/O4VBIykIxJJqSNkeFeKjYCPpWDZ0JDQNys+D7VKtyUURhRgjqaiMzHgUSlXUJ3pXKa0Gq3UvSs+6Jti89qbAu6Qxt0qcRZDIh6cit0c81ZmW7GN8nr6UM5lnUsCMdhVh40dv3n3jUMjFQWHVTgVcQeqLskjxhGQYVuDXa+Ab14vOtXOcciuM3faIo4x161reH7h7PVYiTweDWsHqebiYc0Xc9YVgwBHehhxUEbDAK9DVjdxXSeLaxxFwEVcqAK5zWpytrMfatud/kNct4jc/ZWHqaVyoas5K5k8u2LfxHvWRHl1LE5x+tXtWJSzWsy03GFqls9GnoTSyBVAPC0nnB2CpwKidSxAf7tJEybiI/vCsJI7YMvodrnc2wjv60u9QSx4z+tVA7hpCRuY9R6UyEkqedwPX2rnZ1U3fc01YEhl7dqVJj5x3rxiogQkQxU0LfL865U96yaNr2Y6NXZDIo2rmrkJLnG7iqG58bc4jqVXZRuXpUNFKRoEknCcFO9CF5Jd43GTpVeOVJEOWKv2x3pILoB/LZmV/WhIGaPmzTKyIclByaibKbWBJzwfY0iSojbo2wD973ptteFDKjx7kPINWohc2bGeNothGcUvm4kOz8vSs+3mAUyYwDUpnIYNGuQetMlmj5wEZ+YsfSrJUja4HWsmWUq6Mi8d6sLevMyqRtUVVzJovPI4IO78KXzj5nznt0qi08cg3K/IOKYdpkyz9qdyopFp7kl8Hiq91EzJnflT29KEmTGAN3vUM2WYBG4PWpbLSsXIzEkKqBlqhlAcE7se1Qv5kTqFGaV5FDYNZtF3EAAwc9OfrTWbc+4cGnSFdoC1CW2sBRYpO4eaVVuMMT1oa4kRFGMZ6tUch3SgCpdyP8rdBW0GZVEmxXAkGRx71WjO6fae3b1qeL5T5Z6U7Ysl8Wj6Ba1MXoWbKDyGZmfOentU0TNFcKWO45yKrw5uIDuOMNjNTC2McmS+SOlXE4qt2meoaPcGezhJGDjmtTPYVzHhicvZrn+HiukjOTXRB3PEqK0jgrn5c1ymvygpg9M1014/BzXJ60RIrDBJpsuC1OZ1gqUCeorKSNiqpkhfWti/iHlBmrM3/u328jFS2d8dhhxFKxB3HHGaprEzszk4b0FEMp35b7wzUcs0gYOOQeoFYyOimTJNwIkP7zuTU0SAZUHL98VBD5Tyghtp7k1KmyGSQq4YMMVizqizSSYwqoyCaspI4hZmAyelZSeVtIdyG6irEMpaLaz4Ss7GzeheiMRiPnHJ7YpyS4UAjG+qNvPCkhbBKj1q48sdyIwpCntmpcQUhWcW7Fcbj2qNvMOwyJxnPFPKKz4DZbvUczMboBSwGMYNJRK5ia5uBGrJGMqRz7VYs8x24fadrDGTVKRpIHaKWMHcOCKs2kxaMRzHMI7DrmrURp3Hq+2UZJI9K0ftKzkIg2n1qhMqo4dOVNWIH2je6ZRePl60WsNtExhfa3zk496ckk0bAuPkpIwxldVJAYZG6nxTNLA6SrnB4xUsEhUnGCmAMnIqSS3kRVfd16iooYTKw4wAOtTblf5WY5FJXJfkO3bQAE49alYbUUxOGz19qZgbPm3VJ+7MWIyAe9UwUmRBH3bi2fxqMbtxOKswIDw5NDYQEd6mxSdyjOXLcVG33fmNTy5HTFV5Rkc5p2NIiRMvmAAH61ZMW5tykcdqrW5AmXcPlHep9uDIYslj0FVEiYm3H7zPNSgtFEko/iNRRneCcHA6ipIUMxEb5UDoT0rboc8yeCUTMyY24GcirkTgFWzuK1WEawDIKnPBxUoTfInl4Ve9Cdjmmdb4PuPNuZVYbc9BXYo2I9vvXn3hPc2rlEPAHU16AijZ15zXVTPHxKtI851KQYOK5Ody8kw68V0OrS7FIC81zFm0kl3cbuAFyKbYqe5Rv0zb7W6msS5Xam2P5T3rc1D5o93oaxLtgm4vyD09qzbO6CuUHi/c4Od2etOd7a2IzllPWpkBdF29O4qCSJmmRHUBOp96zZtF2K86xMQYwQppzBBtAP1qURlnlZADEPu07y/MhBKBSP1rNo3jIkRjKoGwegJp8yyLhZscdAvpVaB96iNiygHipnEkcmCueevtUpamt7oswMs74KFEHeriRR5Ur1AqozlnVV+76VclcqYiNoJHapkUiRUdUEm05zxTdr7vOfkjtT0nuYYl84KyA8CnyR5US7iqt2HahDY53jmdWkGzjqabJB5a70mDKTjFZ7xkT4di6nua0YPKjQo+TkcH3plwHW28ts6r3NWGSRA3ltlM5xUUW6KIsQwU96miKi23qSQ3TNEge5ZE53xyMOBwauHaWDR8Kayo2CqPMyR6VZSXaijDH2NQUzRj3RIRnJY/pUbxoW2/jmoBI8oyvGDU6q+B696CR4R2T5cke9I0e0AkgGlMsq/KDxTWG1CXOCelAD0kU8E4qGUsxOKQBGHPFIWaMHLE00rlIjyc4PaoriUgYApzSbW3Y68UjLkbjz7U+UvmsMjJaPB4Y1JHI8ci7OwOamggEibuhH6VWkBUnacnNNIzlK5ZinxC3lplj1NELNINm7BNR2zsiygABcdKrR7kJk5B7Va0MmblsqFhF17E0Fikhj/hXvVfSnZpXDlVJXj3NW5ldCocLz1NHUxqRNDQ7kWV4JipYdK6W78UuuVt7cDHc1xV3L5MSqvLE5GO1NkvDJsBXDdzTqVXFaHPHDqo7sNdmO0844rkNGu3bV54yxIZa3fEU5WA+uK4/Qr+NNaVTgs3FdLPMpo3bxSYnwOM1h3ygoBJwc10F0n72QZ461iX65Vj6c1B2U2U7NzHDMQMkdBUV3OyrHJyT0IpA7RwsU4LVFCxeIpK/JqGbIlVJQzNERsIztz0qW3kkAIChs+9QNAkMJcTFs9qkgyUVo15qWaRLTSK0aK8IVgeoqYMCeRlemfSqipJFHljlmPSrwIjt9j4O45NQzeIxIwsueoNWERAp80HI+6aIVQMpjOfrVu4UNDk8VL1LTsVY4mnAVSz45IHap0WZoGWNflAzzTbcNAA8D7Swwc96fHdvHKNx3LjBoHuUzcAQhduWPepopCoT5B171I8auRJCnye9VVDM77jznIoNI6GobmWSTytoK4qVUXy+ePaqNrLubH8XerUBHnHByPSh6gy7HarMYyroGB6E1ZuF2zgAqygdqoNDE0qswKkdwak3iPocipsLmbZcKfKCnBpG3ADa3NQw3RddqA496JJAhG7JzSKH/Nu+ZuakJ3DnnFVkwZcqaleTcw3cFenvQInG10wFxUcsRJAaozI7cNwPanh1K8k5qojuRsiLw1N2heR0qUMgUnqaQoHQsDVg9RsZABIbg0yW34yjZJ6UkbZBWnxbmOQeVpoz2IXjkiVg5wW6VPE0Is9rqWcdTTbpt+GftULEIoKchqoV7su2bKsrbE3ZXqe1XRKjhRgsay0lIxtGMdTV+BmHzAA1PUmorxFneM/NggDjmq1xOEhaVhtROpq5chpkVMBcmsnXFkbS7mGNST0yKU1cxhKysVfEspdCF6VwViBBraTE87q7bXZA0bYPOK8+VmOosCcHIxXWzyaaPS71f3+4fddBisO9BWNl/Ct4sGt7Uk8hOaxNQwzELyT2qGdCKEUcXk/OOnAqKRY4TtVQc0+TKHDKcGlmiKxb0+b39KhmqZGsbbVjCDYe9Kga3lEeMEciohM42KzHJPPtU8pVnXr5nYmpNIsU7mlBxmQdOeKkffnYwy7HJ5qsMiTc5OR6VcRVTEkbEhuue1QzeLLZt8Rq6NgjrU6yhhtf5ox1xVdCgXYZA2fQ0+J40GzHXgn0qTQmKn7uML1XNQorAOjjrVmRvMiRwwwnFRszLKjMhwe9IosNcP/AGeLbYEPY4qjJC0bAjPTkmtG9bdEJAAWA6Cs8+ZNCWVtyjqB2p2FcbEzI5buetTqflynB71BbsApB+96UiXBRSSvynvSNE7l+1uMN8+Wx2qWWRGOQCprNjl2tuIxmrCyBxnqKTNFEvQS4A5BOelWywbPGOO9ZtsqnJXgjuasLJkBchnPQDvSFIkyI1D5yTUkXz4Z+naqUkrxyETrt9qjExR8qxIJ6UCL7OVm2gHb705nY8oMkdeKZNcqxQIuWHXHamW10LWdw67tw6elCYx3mszfLjHfip1OF+Xp3qgjjexByGPT0qxIJoQN8bKG5GadxE0ZGTtpYiqM3HWoYmAUnPWmElgTyB61pFkNE/ltLlVHFVpQ8EwWQZx0FL5hTGGanzvt+dss2Oc9qshCNORCYkTLtVvTpWeIKeOxzVRSUAuFZWzwQO1SQS7SORlu1T1LavE1bsBLZJB8zZ4warQ3dwLJ1KqS56FafcMp0wHJ3g/L71yWveIZ7LUI4rba2Fy3tUzZyKOthdWfJIrhdSHk30chOBursNTkO/OK5PWgJB84wM9a7DyUejwN5ljbyJyNtZV+XaXgAVb8OSNJ4ehK84GKguoiQZe47VEjaCMvZuDEsd+e9CMRIEbIX9KmmDFMgDHeo95e0bgEg1kzpghpcPJtMSnnk+tPvWSQxmKIqV4zUTorYwMMB1HenWuw/JI5UA9aRbViTyw0e5e3Wo42x8rdCasIpjc+X8yn1qLyXkkYONh6ipextFlo+WjAqOcVHI5/i706ElImMgyRxxUKANtWSTCnoTUmiZZVFEAHmcnoKnW4kZo0cfIves50C3BVWLY6VLG00TsjjII4prYq5qRtG5k8snOKz4Wm8maMMBznjqadpyM/msHxgdDWfas63jsCWKNkr2NMLl+KeF40UDEinDVPewxwwB0bcDztpiS28tyziNUVhz7GoZdskRCuflPFA4j45hOwXbjA6U9GwpU8DNQWdvKxMkZBz69qmdCjhGIOetS0a85etlQyBd3DDk5qYRo048lwrocA1SPlptwTuHpT/tJKbYUG496mwcxp+UiyF7pi70ExySAIgDD7vFZ4MwIEmMH3pTIELEHBXvTsZuSRLGzR3Mg2/PToZXRJCUDv6+lRxyeWxlLcN1Zqj+2W0BlAmU7x1J6UKNyHXsOcCOPcMq7c1NNczTGIyZAUYzmqaXaeRhZRIQe/pSi6RgCoyR2FPkGq6ZaZyqnKEj1p8WwRNIGbI/hNQRXNxJktEQn0pYJwwIIUHOCKErDdVMVmJAbsDVqZ0uPJAYKW4aonyibSmSelSxw+ZE8ZiAl4IYda0uQ5kqxwx2s6KCWVsj3qpPJ++QgYGOae0hTPUYGG+tRrMmw+aOW6VJcdS8VNxYs8bcIa831KJ1vLkzMdzHivUdGjja0kQZOBux61w/iOFLq9DRqQwOCMVE3ZoiPxMn1ZcHiuP1ggRtn3rtr5cg1x2tx/u5QTjIruPCR2fgkl/DcYq5MoClD1rP8AApxoESgZIJrYZEMuSvNRI6Ka1MRWAZ4mFRiPHyDjdV24iLTM23GKoXKsfnHWsmdcEMRdkh3HNQTsBIFThj0JqeKEsxyefSlkjVjtdaku1yzFcLMFUgfIMEimGE/NKCducVAsbxH5DhfSpfPRVwSwb0Hek9SuWxcWBhbbo8Nnrmq1/D5ixBUwFGSant389cW4Yv3qObe6MgOYM/N9aVhqVinHGJY/3YIkJ60loJJ7mSKTdvQetWFJ8xYyMAdDUEcZk1aT58YSmkUpFm0BG9GGO3WoIpktbpkEeSRyRT4EYtyDsHX3pXMEV3E8fysVIJNK4xCEnU7PlGeauQW0MjFVzjHWq+F807OCe9RS3LWL/NIWiblgOxpjcrFrYbZZY1OfSpvMjQLuTLEVmQajBqG/adsqdfpU8a5/i3UxRnoTszeYWKgD0oDSD5kAqKRtgx90nrWHPqQjuDGshAHP1osS6ptX+qQ2yK1w/wA3pmsk+JEmuVjiQlD1NY8t1DJdGW4XzAf4aWJYZZmeD5McBaDLmbNC6v55pSvmFovQVVCtNIPvVcsLBmY4JLN2rb0nRpZmdzhccfNRsS0YccbpKVRyp2569a0bC/ktbbM0OPmxuNaI0mCLc7MWlBzjtVS+X7TIGPCrxVIVjUudUMgULJsiK9h3qJCNsaxnew+ZiaxoVKSEscjOFFXJE8idFkPyv1FKwJs6BLqW7KfIFVeM4pbu5lhnjMPzYHzGora98pkRY8KoHNT3F9brbyR7d7nnilY0hLXUigmMySBgN2cmq8bsbhHZcoD0pII1uNqwAozU6TNuSnWQdaR3actzd0a5WKUy7eCCAKy7u3FzcyNsC85q9ohaWZVH3mFbN5ZR29s2P9aazqLYwhuzhb0YBrk9aRXBDGuwvyFU+tcdqgJLmu88KJ0XgiUx6VhRwjYrcmuCHyF5H61zHgu4AtbiEnkHNdNbOkwZZflIHHvUSOiBBJNwWfAHpUEZhkbkjB7Ug6TCT7oOAartGihfLbk1kzZSsWNkDHCuA/c5pFRC+0MC3Y1liKRWkjZfnboc1i6gtzGxaK5YOvRaLGymda/lo2JBz7UnkeZ8yp8nr0rh3vNUiCyE7j71eg8SagIws9tuHqDiixfOdSsKwEmKUqxGDTbfcsTxhcr1PPWucPihW+VbVi3sa1LbWree3X920cncGlYOYuu3mIOz9MelZrELqqsMnIwcGprrU7f5TH94dagsFMlwZJOjdKGClqXriV4mQR8p0IpLsQyiIbCCvPWrEqoIwRUEoV2BBwcVn1N4rQYrqW4Bx6VI4JVVaIFD69TTIJER8SjA9aW8uokkRkkBXsKoiRl3ltHb3HnW3+tPVRS21zMxwwIxRfXYhLsU5foajt5WEZdx8ppmEmOvZnZWMblmA+5WZb2l3dJ5josa579alm1JoWIhQMp6tVae8uZECKTsJ7UiNy3Y6cQ03Qt2JrV0zTooSksgBkPb1rDhuZ4zhEZh3NadncOGBOcn17UrmiR0scXkAzR7fMPRcdKtR4jkjMcv+s6huxrMtZwmGzvb0q/NcxCNC2GYf3R0pl2JJ1JuHKqcKOfQ1QlhyhOwkZyeKsNqa24LEjaR0ByRVRNQuJw/kKxjb2qXKwcpItpE6Boxhs55NTolufMNx80+PkHpUFppk1wP3jtEa19P04LIqSkO3ZqdxcpWhkZ4DEYxk/x+lTqtnDht3zKOcjrV9tOI80wHcF6ioZVja0EZgIcc78UmwULksiwnT1lijMcmchsVkRMGErS/NJ61ZElwqiJi3lHgcU7YY1JWLIHU0rm92lYs+G5dlxkjB9a2Tc/ar0qQTjvVLw5FHIz7iFLHg+lbsEENrKzPIjn2rKpJkxklc85vTlDXN36ggjHeujuPuEVg3oG7FemeEnqReGGCXtyv97pXQFmRw5JIHFcto0gh1Vdx4PFdNM5BwcYqJHVAsS4JBc4Rqo3FpIZBJDJwKspIrxYkHyjpmmi6SIFSuc9MVkzSI+C2NwSZGAkx1qve2UEsQjcASIc7h1NO2yMGIJAP3cVKw2rkqWJHNFzRRMa409AmQ5Psaz3iYZViAK2LqJmGQCBWXPFvPUjHFSnqXymbJCYyTFjPrVQQ3jnMbfN9a0pLd15BwP8AaqBtkWJnnAJ/hBqrg42RVhZ0mCz/AHxW/YXKbtpk/edhnisKaeJg5RgWbqfSqcRdLgAMSBySOtPoZp2Z6GsZe2yWyfal8oGLIG1gOprM012mgXZL271Yura6DDbPhSKxkdcJXRfS2YwCSVFCHuap3cVqG2Kys45GOlRQ2c8ieXdXTtH/AHRVyC1t4F8vbgHuTzSTLeqOV1W8Z93mIVVOM9qyrm/u2220Z+Trmul1exe9DxhcW6c7gOtY99pcavE0EuGA5BqtzlmivbO9qMt8/qDUFxdzMzNb9cdBWibVWhBBOTxmoP7Pa2YOvO7rVoUEV9J1fVbKGXdCsgk6ZXpVm31bUIhuktg2f0rWgljKBNoOKlaW3T/lkd1DubJRM5NU1K5UiBFib1xV6zivpCPtMuB3watxM05UQRKg96u2Vo0lwEYMT146VnZsvRbEccQBwIyWPG4966vRVMcUkcsaqMcECljto4rcbgCfftVq32iKQhgS3SjlJbJpItseVGVA701LhYYkPkHjq1VmuJPK8uTgg8e9BuS+A5/c919apsSi2WYr2a0kZgvyv+NU2v5JZGBQ+WeuB0q2xGQe2OBVJXke8ZV2ruGKzbNoRsRvfPIxjgOFX+9Uj3U0VsUdR81RLEsEjGVdy56r2NABmYhiSvaqiKWhM801vppa0GZCeah0+a+luFjKsxbrW3YiO3jAYBgeua0baCBlaa3bY9EoxZCbseeXsoDcVh3rghvWrV5OTL14rLunJY46V2ngGaZjFdwSDoG5rrJJBIFdR98ZrjbocECun0S4+02EYPLJ8tRI6aci2ZXiT7u8elEU8N3GysNj0swa3mznII4FY00rw3W5RgE81m0dCdi4y3VrPGyyloc9KtTXdyrmSFQ0ePmFMgvYnTEoHPemvm2bfG+VPas2bxmilJrciOwktXK/Ss651iV8rBaMCeckVsTX6tyY1JqlcazGvym1XPsKSizWMkZEaahqbeXMWjXtikutGSzQtKWdx2rTOtOE/dwhffFVJLqVmLyHIPXNMUmmY9gqXN+u47UXtVmVPs108ifMp4FTP5RYOIwCe4qWFUlQrjntVJ6WOaaNbR/LeNWBwx7VvPDMdoUhh1rm9LhKSbj0HWuot281VCnGKyqOyNKTZPa2Ek7gyNsIq1PpsQJJcs561fsot20k81eurdnj29M9DisVI6+hzlx5ZjEMQ6dR61k/Y45gxMPzKcV0r2ciAxwx5J+8ahit3t2aJo+W5raMkZTgc/JphMRjZdoxkVROUjMUqewNdNueR3jZcqtQXlmspyV5xxWikiIqxzVtDGknStBYYWySMYoW2aEKZF5J61JCow7TAtjhQKTmaJot2McZ4xitD7QtthlXB6cVTtPKS1cN8sw5BNWLMBgQ5Vx1qea5omjUS6R7fawGW45qOGR1DR7RheR71Qjt2lnbecAcjFXEB+7nNK7HZMl8qW9wzfIBQwC8Eghe1ONzGsJRmw44qlIQMHlsmi5cYk80sjLk8KOmKqlmBVgxJHers0qRx7IE+8OQe1UiufTFTYtWLkEwW2kV+WboaTTyRJhulV+cDjNX7ZMgH860ijmqs1bDS7rUvMgssNIeRXQ6N4K1Mqi30ojB9DUfw9YprTsMgBa9HSTcWJJOORzXRCkpanmVcXOD5UfItzJ3JqsWBGSaSZ91R7uMGtDjKtxyaveG5zHO8bcKeRWfOwzUNpM0N4rZ4JqWXB2Z2lyGmUEH5hxisq/hfcBnmteDDRK+eCKq3Y2ktjOeKzZ2R1RnPFus1QH5161XF08QXzMsq1adXgwuc55NQzSJk5j49azZoiN5opPmVSM1XlVW+6efSlfEh+TiljVYjhn5PIpmiI3YxoAf5UrkSR7VGTSyM5PYrUseYXWQgbWHSkFysqBogPSnRRvHICo+WpxEx+fGAx6Vet7YMtCIlqSWiFVzjrzW9p4/d4xVCCDCitO2QhABWdQ0po3NOGWHNdFBGrRlmOdvaue0+IRlWY1uxSEsu37h61z7HXbQqXUTo3mRuBntVPZMZPMlWtecIZahuWCpjFCkU43MG4UpI0gXCkc1WtLpHikDD5weBW1IA6Y2jFUZdPizlTtPtWikZuBTuoPtEUIVfn6kVSXT5cyPnaE5x61uW0PzMS7ccCkns2ypDnd6HvVJ3JcbHNiWTzDIyjPTBqRbfyZA8TFweTg9K1rrTpEj5UbmqraRrHcOS2xQOQau1iU9S3bFCwZepGOajnDxuWHAqRYoTMsgDFO+KiiuPmmCITF6mg2iSMkRg3HmVhn61WjkZNrYwQeM02SUj/VDJq1OqfZoWLfvD1FSbXS0Gyz+dIxxtyO1OiVWAK5GOMVAAKnj4XNNEzdkTjCDLDirVuuYy3Qdqpj5uD0q6o2oR2xW0UclR3Os8CqTNJJ7YBrv4WG3r2rhPBMbJET2Jru7eP8AdkmummeLifjPkAjFRykAdafO4Uc1mXM/HBFSQNuJOeKpyyc8H5hzTJZSWqINk7j9KBpndaDdNNZJkg4GDWmx+TGAc+tcj4TuSplhJ68iusjIK81Ejuou6I2fI8ny1LN0Y1lXlvJG5jYH3rYliDYYMQy9DVJo2lkbfJ83bNZM1RlGMx5Qqd3WkVFIDOMt71oursBKwAP3agaPyyVbB9CKRpa5B+7kwrDA9qWeB0lAyXRemKkEanrwaniRtgC/rSZSgQwqw59ex7Vp2qnbzUSpzg9quQKMUrhKNi1EOBgcVpaeoZvbFUIhtGPWr9qDGAB1NTLYIaGkqDIIJwK19PkBiIBrKi+RMHnNWbZ/L6Hr2rCSOuOppkcrnrUV0m4cmpX+aBW71WmJIHNQWQNGA27JziqlxMqNz1q3O/ljk1mzOsmcjBq0VFXLEMwKggnOc1NNIZSN/U+lYqStG+M8VYW73K2eo6VSKdNNFpgWYIGYsO5qv5UImc3CseKBNvTCnD+tG7e23JJ963i77nO6diq+CoMBYLuwR7UyWYshhTAXqandZlOzChOuajiiXc27k0MuCKwz14zjAxSjcR8zZx0FTKiRNnqD1FTZi42KfxosVKxAgyPep1OxNpHPrSFO44oXJPJGKdjGbuWrdNwycVcwWAXtVWEccKSPUdKvWURkmRT/AHuK1ijmm7RPRPCNkU06JmHJrqo0ATb2rP0lRDaxR+gFaUZy1dEdEeNUfNLU+Gbm7ZxVBmLGrc0fFVyAtRYVxgXJ5oOFzTXkIPb86rSyZJOelCQmzW0W4EWopk9Riu7tmBUfSvLILgrdRMB3Ar0TT7gMgI9KmSOui9DV6x8dKrSKN2Dx71JDwfvcU6bkE7MismjsiQOwEJRhn0NQvGm1VTk4yalkz5WPX9KYAqn0IH51JrEiijCyFpBx2qbYAu4HJqZZ43gCtHgnvTEUKeKTNULGSwGRirsEW4VUwVYE9DWlaSLnBqRyV0WI4vmWre0hhikLRREEyA/SnN8+GiORSZhsy6soICjrViKPLL61npwwJHNbFkAxUk81lLQ6IPQt4YRgVWdepJxitOTAUcZrF1UnBSMkE+lSkmU5FG9vIkYqzAkCsWS9LyEKeKoatp9+qvKu5hXMw6u8d15E6lDnGa1UCoysdr525sk1YV1dfl7dawLefdznIq4kpAyh471KR0xlc14XRPvU8OwOQazEkLdRViOcD75I+lWiHYvF3ZcdfrUTZA+b5W9BT4WB+dwNnY5701ple4DY6dqtMhIfsJ8sbeSKnW3Xqz4IpRNumV8DA7Us679zR8k9qZMrkLAqcDkU3auckYq0xC2+VGW71VTk7mORTRiy9bu+3anCng1saNGHvogo+6ayoASBtHFdN4Sg3XRcjODW8DirytE9Bs0IRd3pxWnGvy1QtlOAWP0rQTgVseS3qfCs/Ss+XrRRUAVLnpUP8NFFAEf8SfWvQNF/1CfSiipkdVE3E6VP/wAsm+lFFZs7I7lY9KYf9YPpRRWbOiI6QDA4o7iiikaomf7qU+LrRRS6gyOBifMyT1q7pbN55G44x60UUmYPc3rf/WCta3/1tFFYT3OiGxqy/wCrrJl/4+xRRRDcY/UFH2RuB0rxHxgANR4AHzdqKK6EBraIc23NbMf3TRRWZ0wJ4qmH+rNFFNEy3JoSfs/WiL79FFUNF1fu1as/umiiqREgl6Gq6dB9aKKDE1bP/Vmuu8IffaiiuiB5+J2O9g6LVxelFFbHks//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Alopecia is common in patients with mycosis fungoides and S&eacute;zary syndrome and can present as reduced hair density diffusely over the scalp and body or as patches of alopecia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Localized alopecia in follicular mycosis fungoides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Alopecia is common in patients with mycosis fungoides and can present as reduced hair density diffusely over the scalp and body or as patches of alopecia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41623=[""].join("\n");
var outline_f40_41_41623=null;
var title_f40_41_41624="Imipramine: Drug information";
var content_f40_41_41624=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Imipramine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/18/36133?source=see_link\">",
"    see \"Imipramine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/5/31831?source=see_link\">",
"    see \"Imipramine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tofranil-PM&reg;;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Imipramine&reg;;",
"     </li>",
"     <li>",
"      Novo-Pramine;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F182180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidepressant, Tricyclic (Tertiary Amine)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F182141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Depression:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Outpatients",
"     </i>",
"     : Initial: 75 mg/day; may increase gradually to 150 mg/day. May be given in divided doses or as a single bedtime dose; maximum: 200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Inpatients",
"     </i>",
"     : Initial: 100-150 mg/day; may increase gradually to 200 mg/day; if no response after 2 weeks, may further increase to 250-300 mg/day. May be given in divided doses or as a single bedtime dose; maximum: 300 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Maximum antidepressant effect may not be seen for 2 or more weeks after initiation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Post-traumatic stress disorder (PTSD) (unlabeled use):",
"     </b>",
"     Oral: 75-200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      MAO inhibitor recommendations:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Switching to or from an MAO inhibitor intended to treat psychiatric disorders:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 14 days to elapse between discontinuing an MAO inhibitor intended to treat psychiatric disorders and initiation of imipramine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 14 days to elapse between discontinuing imipramine and initiation of an MAO inhibitor intended to treat psychiatric disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Use with other MAO inhibitors (linezolid or I.V. methylene blue):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Do not initiate imipramine in patients receiving linezolid or I.V. methylene blue; consider other interventions for psychiatric condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If urgent treatment with linezolid or I.V. methylene blue is required in a patient already receiving imipramine and potential benefits outweigh potential risks, discontinue imipramine promptly and administer linezolid or I.V. methylene blue. Monitor for serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or I.V. methylene blue, whichever comes first. May resume imipramine 24 hours after the last dose of linezolid or I.V. methylene blue.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F182158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/5/31831?source=see_link\">",
"      see \"Imipramine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Depression:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children (unlabeled use):",
"     </i>",
"     1.5 mg/kg/day with dosage increments of 1 mg/kg every 3-4 days to a maximum dose of 5 mg/kg/day in 1-4 divided doses; monitor carefully especially with doses &ge;3.5 mg/kg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Adolescents:",
"     </i>",
"     Initial: 30-40 mg/day; increase gradually; maximum: 100 mg/day in single or divided doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Enuresis:",
"     </b>",
"     Oral: Children &ge;6 years: Initial: 25 mg at bedtime, if inadequate response still seen after 1 week of therapy, increase by 25 mg/day; dose should not exceed 2.5 mg/kg/day or 50 mg at bedtime if 6-12 years of age or 75 mg at bedtime if &ge;12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Adjunct in the treatment of cancer pain (unlabeled use):",
"     </b>",
"     Oral: Children: Initial: 0.2-0.4 mg/kg at bedtime; dose may be increased by 50% every 2-3 days up to 1-3 mg/kg/dose at bedtime.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      MAO inhibitor recommendations:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F182142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Depression:",
"     </b>",
"     Initial: 25-50 mg at bedtime; may increase every 3 days for inpatients and weekly for outpatients if tolerated to a recommended maximum of 100 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      MAO inhibitor recommendations:",
"     </b>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15897618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15897619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F182116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as pamoate: 75 mg, 100 mg, 125 mg, 150 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tofranil-PM&reg;: 75 mg, 100 mg, 125 mg, 150 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 10 mg, 25 mg, 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tofranil&reg;: 10 mg, 25 mg, 50 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F182101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Tofranil&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089161.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089161.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Tofranil-PM&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F182120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of depression; treatment of nocturnal enuresis in children",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F182176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Analgesic for certain chronic and neuropathic pain (including diabetic neuropathy); panic disorder; attention-deficit/hyperactivity disorder (ADHD); post-traumatic stress disorder (PTSD)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F182188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Imipramine may be confused with amitriptyline, desipramine, Norpramin&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high [moderate for SIADH]; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F182178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Reported for tricyclic antidepressants in general. Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, CHF, ECG changes, heart block, hypertension, MI, orthostatic hypotension, palpitation, stroke, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety, confusion, delusions, disorientation, dizziness, drowsiness, fatigue, hallucination, headache, hypomania, insomnia, nightmares, psychosis, restlessness, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, itching, petechiae, photosensitivity, purpura, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast enlargement, galactorrhea, gynecomastia, increase or decrease in blood sugar, increase or decrease in libido, SIADH",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, anorexia, black tongue, constipation, diarrhea, epigastric disorders, ileus, nausea, stomatitis, taste disturbance, vomiting, weight gain/loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence, testicular swelling, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, eosinophilia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Ataxia, extrapyramidal symptoms, incoordination, numbness, paresthesia, peripheral neuropathy, tingling, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, disturbances of accommodation, mydriasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, falling, hypersensitivity (eg, drug fever, edema)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F182123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to imipramine (cross-reactivity with other dibenzodiazepines may occur) or any component of the formulation; in a patient during acute recovery phase of MI; use of MAO inhibitors intended to treat psychiatric disorders (concurrently  or within 14 days of discontinuing either imipramine or the MAO inhibitor); initiation of imipramine in a patient receiving linezolid or intravenous methylene blue",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F182105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Major psychiatric warnings:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal thinking/behavior:",
"     <b>",
"      [U.S. Boxed Warning]: Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (18-24 years of age) with major depressive disorder (MDD) and other psychiatric disorders;",
"     </b>",
"     consider risk prior to prescribing. Short-term studies did not show an increased risk in patients &gt;24 years of age and showed a decreased risk in patients &ge;65 years. Closely monitor patients for clinical worsening, suicidality, or unusual changes in behavior, particularly during the initial 1-2 months of therapy or during periods of dosage adjustments (increases or decreases); the patient&rsquo;s family or caregiver should be instructed to closely observe the patient and communicate condition with healthcare provider. A medication guide concerning the use of antidepressants should be dispensed with each prescription.",
"     <b>",
"      Imipramine is FDA approved for the treatment of nocturnal enuresis in children &ge;6 years of age.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; The possibility of a suicide attempt is inherent in major depression and may persist until remission occurs. Patients treated with antidepressants should be observed for clinical worsening and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases. Worsening depression and severe abrupt suicidality that are not part of the presenting symptoms may require discontinuation or modification of drug therapy. Use caution in high-risk patients during initiation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prescriptions should be written for the smallest quantity consistent with good patient care. The patient's family or caregiver should be alerted to monitor patients for the emergence of suicidality and associated behaviors such as anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, and mania; patients should be instructed to notify their healthcare provider if any of these symptoms or worsening depression or psychosis occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems. The degree of anticholinergic blockade produced by this agent is high relative to other antidepressants.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: TCAs may rarely cause bone marrow suppression; monitor for any signs of infection and obtain CBC if symptoms (eg, fever, sore throat) evident.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension (risk is very high relative to other antidepressants); use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitization: Has been associated with photosensitization; avoid excessive exposure to sunlight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May cause sedation, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). The degree of sedation is high relative to other antidepressants.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Serotonin syndrome: Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents (eg, SSRIs, SNRIs), particularly when used in combination with other serotonergic agents (eg, triptans, TCAs, fentanyl, lithium, tramadol, buspirone, St John&rsquo;s wort, tryptophan) or agents that impair metabolism of serotonin (eg, MOA inhibitors intended to treat psychiatric disorders, other MAO inhibitors [ie, linezolid and intravenous methylene blue]). Monitor patients closely for signs of SS such as mental status changes (eg, agitation, hallucinations, delirium, coma); autonomic instability (eg, tachycardia, labile blood pressure, diaphoresis); neuromuscular changes (eg, tremor, rigidity, myoclonus); GI symptoms (eg, nausea, vomiting, diarrhea); and/or seizures. Discontinue treatment (and any concomitant serotonergic agent) immediately if signs/symptoms arise.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with a history of cardiovascular disease (including previous MI, stroke, tachycardia, or conduction abnormalities); the risk of conduction abnormalities with this agent is high relative to other antidepressants.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; may alter glucose regulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mania/hypomania: May worsen psychosis in some patients or precipitate a shift to mania or hypomania in patients with bipolar disorder. Monotherapy in patients with bipolar disorder should be avoided. Patients presenting with depressive symptoms should be screened for bipolar disorder.",
"     <b>",
"      Imipramine is not FDA approved for the treatment of bipolar depression.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with hyperthyroidism or those receiving thyroid supplementation due to concerns of pro-arrhythmogenesis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in this age group due to its potent anticholinergic and sedative properties, and potential to cause orthostatic hypotension.In addition, may also cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Discontinuation of therapy: Recommended to discontinue prior to elective surgery requiring general anesthesia. Therapy should not be abruptly discontinued in patients receiving high doses for prolonged periods.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; ECG monitoring: Baseline and periodic assessment recommended with use of higher dosages; should also be considered in elderly patients and/or patients with pre-existing cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electroconvulsive therapy: May increase the risks associated with electroconvulsive therapy; consider discontinuing, when possible, prior to ECT treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F182174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2B6 (minor), CYP2C19 (major), CYP2D6 (major), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2D6 (moderate), CYP2E1 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F182110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Tricyclic Antidepressants may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Agonists: Tricyclic Antidepressants may enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: Tricyclic Antidepressants may diminish the antihypertensive effect of Alpha2-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Altretamine: May enhance the orthostatic hypotensive effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Tricyclic Antidepressants may enhance the stimulatory effect of Amphetamines. Tricyclic Antidepressants may also potentiate the cardiovascular effects of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Tricyclic Antidepressants may enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BuPROPion: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cinacalcet: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Moderate): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Strong): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Tricyclic Antidepressants may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Dexmethylphenidate may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DULoxetine: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Tricyclic Antidepressants may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the serotonergic effect of Tricyclic Antidepressants. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: May enhance the neurotoxic effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the serotonergic effect of Tricyclic Antidepressants. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylene Blue: Tricyclic Antidepressants may enhance the serotonergic effect of Methylene Blue. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Methylphenidate may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Management: Seek alternatives to this combination when possible. Monitor patients receiving metoclopramide with tricyclic antidepressants for signs of extrapyramidal symptoms, neuroleptic malignant syndrome, and serotonin syndrome.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of CYP2D6 Inhibitors (Moderate).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Tricyclic Antidepressants may enhance the QTc-prolonging effect of QuiNIDine. QuiNIDine may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Tricyclic Antidepressants may enhance the adverse/toxic effect of Sodium Phosphates. Specifically, the risk of seizure and/or loss of consciousness may be increased in patients with significant sodium phosphate induced fluid/electrolyte abnormalities.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May increase the metabolism of Tricyclic Antidepressants. The risk of serotonin syndrome may theoretically be increased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Cyclic Antidepressants may enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Terbinafine (Systemic): May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: Tricyclic Antidepressants may enhance the neuroexcitatory and/or seizure-potentiating effect of TraMADol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Tricyclic Antidepressants may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: Tricyclic Antidepressants may increase the serum concentration of Yohimbine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F182132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease imipramine levels. Management: Avoid valerian, St John's wort, tryptophan, SAMe, kava kava (may increase risk of serotonin syndrome and/or excessive sedation).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10949669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies are inconclusive. Congenital abnormalities have been reported in humans; however, a casual relationship has not been established. Due to pregnancy-induced physiologic changes, women who are pregnant may require dose adjustments late in pregnancy to achieve euthymia.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F182145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended (AAP rates &ldquo;of concern&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10949670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Imipramine and its active metabolite (desimpramine) are excreted into breast milk. Concentrations of imipramine may be similar to those in the maternal plasma. Based on information from five mother/infant pairs, following maternal use of imipramine 75-200 mg/day, the estimated exposure to the breast-feeding infant would be 0.1% to 7.5% of the weight-adjusted maternal dose. Although adverse events were not reported, infants should be monitored for signs of adverse events.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F182125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Imipramine Pamoate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg (30): $505.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (30): $505.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (30): $505.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (30): $505.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Tofranil-PM Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg (30): $658.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (30): $658.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (30): $658.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (30): $658.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Imipramine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $42.96",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $71.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $121.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tofranil Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $209.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (30): $209.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (30): $209.52",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F182113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC, ECG in older adults, with high doses, and/or in patients with pre-existing cardiovascular disease; monitor blood pressure and pulse rate prior to and during initial therapy; evaluate mental status, suicide ideation (especially at the beginning of therapy or when doses are increased or decreased); signs/symptoms of serotonin syndrome; blood levels are useful for therapeutic monitoring",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F182117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic: Imipramine and desipramine: 150-250 ng/mL (SI: 530-890 nmol/L); desipramine: 150-300 ng/mL (SI: 560-1125 nmol/L); Toxic: &gt;500 ng/mL (SI: 446-893 nmol/L); utility of serum level monitoring controversial",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F182126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Antidep (IN);",
"     </li>",
"     <li>",
"      Celamine (TH);",
"     </li>",
"     <li>",
"      Chrytemin (JP);",
"     </li>",
"     <li>",
"      Depsol (IN);",
"     </li>",
"     <li>",
"      Depsonil (IN);",
"     </li>",
"     <li>",
"      Ethipramine (ZA);",
"     </li>",
"     <li>",
"      Eupramin (HR);",
"     </li>",
"     <li>",
"      Feinalmin (JP);",
"     </li>",
"     <li>",
"      Fronil (TW);",
"     </li>",
"     <li>",
"      Imidol (JP);",
"     </li>",
"     <li>",
"      Imilanyle (JP);",
"     </li>",
"     <li>",
"      Imimine (TW);",
"     </li>",
"     <li>",
"      Imine (TW);",
"     </li>",
"     <li>",
"      Melipramin (CZ, HN, HU, PL);",
"     </li>",
"     <li>",
"      Meripramin (JP);",
"     </li>",
"     <li>",
"      Primonil (IL);",
"     </li>",
"     <li>",
"      Pryleugan (DE);",
"     </li>",
"     <li>",
"      Sermonil (TH);",
"     </li>",
"     <li>",
"      Talpramin (MX);",
"     </li>",
"     <li>",
"      Tofranil (AE, AR, AT, AU, BB, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CN, CO, CY, DE, DK, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, GY, HK, ID, IE, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MT, MU, MW, MX, MY, NE, NG, NL, NO, NZ, OM, PH, PK, PL, PT, PY, QA, RU, SA, SC, SD, SE, SK, SL, SN, SR, SY, TN, TR, TT, TW, TZ, UG, UY, VE, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Tofranil-PM (AR);",
"     </li>",
"     <li>",
"      Tolerade (AU);",
"     </li>",
"     <li>",
"      Topramine (TH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F182104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Traditionally believed to increase the synaptic concentration of serotonin and/or norepinephrine in the central nervous system by inhibition of their reuptake by the presynaptic neuronal membrane. However, additional receptor effects have been found including desensitization of adenyl cyclase, down regulation of beta-adrenergic receptors, and down regulation of serotonin receptors.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F182122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak antidepressant effect: Usually after &ge;2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, primarily via CYP2D6 to desipramine (active) and other metabolites; significant first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 6-18 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical Practice Guidelines: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity Disorder,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(4):1033-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/11581465/pubmed\" id=\"11581465\" target=\"_blank\">",
"        11581465",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bandelow B, Zohar J, Hollander E, et al, &ldquo;World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders -- First Revision,&rdquo;",
"      <i>",
"       World J Biol Psychiatry",
"      </i>",
"      , 2008, 9(4): 248-312. Available at file://www.wfsbp.org/fileadmin/pdf/guides/Guidelines_Anxiety_revision.pdf",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/18949648/pubmed\" id=\"18949648\" target=\"_blank\">",
"        18949648",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Benedek DM, Friedman MJ, Zatzick D, et al, &ldquo;Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder.&rdquo; Available at  file://www.psychiatryonline.com/pracGuide/loadGuidelinePdf.aspx?file=AcuteStressDisorder-PTSD_GuidelineWatch",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berde C, Ablin A, Glazer J, et al, &ldquo;American Academy of Pediatrics Report of the Subcommittee on Disease-Related Pain in Childhood Cancer,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1990, 86(5 Pt 2):818-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/2216644/pubmed\" id=\"2216644\" target=\"_blank\">",
"        2216644",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boakes AJ, Laurence DR, Teoh PC, et al, &ldquo;Interactions Between Sympathomimetic Amines and Antidepressant Agents in Man,&rdquo;",
"      <i>",
"       Br Med J",
"      </i>",
"      , 1973, 1(849):311-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/4685619/pubmed\" id=\"4685619\" target=\"_blank\">",
"        4685619",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bril V, England J, Franklin GM, et al, \"Evidence-Based Guideline: Treatment of Painful Diabetic Neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2011, 76(20):1758-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/21482920/pubmed\" id=\"21482920\" target=\"_blank\">",
"        21482920",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Callaham M and Kassel D, &ldquo;Epidemiology of Fatal Tricyclic Antidepressant Ingestion: Implications for Management,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1985, 14(1):1-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/3964996/pubmed\" id=\"3964996\" target=\"_blank\">",
"        3964996",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fortinguerra F, Clavenna A, and Bonati M, \"Psychotropic Drug Use During Breastfeeding: A Review of the Evidence,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2009, 124(4):e547-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/19736267/pubmed\" id=\"19736267\" target=\"_blank\">",
"        19736267",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fouron JC and Chicoine R, &ldquo;EKG Changes in Fatal Imipramine (Tofranil&reg;) Intoxication,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1971, 48(5):777-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/5121238/pubmed\" id=\"5121238\" target=\"_blank\">",
"        5121238",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frommer DA, Kulig KW, Marx JA, et al, &ldquo;Tricyclic Antidepressant Overdose,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1987, 257(4):521-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/3540330/pubmed\" id=\"3540330\" target=\"_blank\">",
"        3540330",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hagerman GA and Hanashiro PK, &ldquo;Reversal of Tricyclic Antidepressant-Induced Cardiac Conduction Abnormalities by Phenytoin,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1981, 10(2):82-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/7224255/pubmed\" id=\"7224255\" target=\"_blank\">",
"        7224255",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mitchell JR, &ldquo;Guanethidine and Related Agents. III Antagonism by Drugs Which Inhibit the Norepinephrine Pump in Man,&rdquo;",
"      <i>",
"       J Clin Invest",
"      </i>",
"      , 1970, 49(8):1596-604.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/5431666/pubmed\" id=\"5431666\" target=\"_blank\">",
"        5431666",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nelson JC and Devanand DP, \"A Systematic Review and Meta-Analysis of Placebo-Controlled Antidepressant Studies in People With Depression and Dementia,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2011, 59(4):577-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/21453380/pubmed\" id=\"21453380\" target=\"_blank\">",
"        21453380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nies A, Robinson DS, Friedman MS, et al, &ldquo;Relationship Between Age and Tricyclic Antidepressant Plasma Levels,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1977, 134:790-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/869057/pubmed\" id=\"869057\" target=\"_blank\">",
"        869057",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pass SE and Simpson RW, &ldquo;Discontinuation and Reinstitution of Medications During the Perioperative Period,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2004, 61(9):899-912.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/15156966/pubmed\" id=\"15156966\" target=\"_blank\">",
"        15156966",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roose SP, Glassman AH, Attia E, et al, &ldquo;Comparative Efficacy of Selective Serotonin Reuptake Inhibitors and Tricyclics in the Treatment of Melancholia,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1994, 151(12):1735-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/7977878/pubmed\" id=\"7977878\" target=\"_blank\">",
"        7977878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sener EK, Gabe S, and Henry JA, &ldquo;Response to Glucagon in Imipramine Overdose,&rdquo;",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1995, 33(1):51-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/7837313/pubmed\" id=\"7837313\" target=\"_blank\">",
"        7837313",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sovner R and Orsulak PJ, \"Excretion of Imipramine and Desipramine in Human Breast Milk,\"",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1979, 136(4A):451-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/426114/pubmed\" id=\"426114\" target=\"_blank\">",
"        426114",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Svedmyr N, &ldquo;The Influence of a Tricyclic Antidepressive Agent (Protriptyline) on Some of the Circulatory Effects of Noradrenaline and Adrenalin in Man,&rdquo;",
"      <i>",
"       Life Sci",
"      </i>",
"      , 1968, 7(1):77-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/5636628/pubmed\" id=\"5636628\" target=\"_blank\">",
"        5636628",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tran P, Panacek EA, Rhee KJ, et al, &ldquo;Is Norepinephrine More Efficacious Than Dopamine in Reversing Hypotension Caused by Cyclic Antidepressant Overdose?&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1995, 25(1):128-30.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vetter VL, Elia J, Erickson CH, et al,  &ldquo;Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs. A Scientific Statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2008, 117:2407-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/41/41624/abstract-text/18427125/pubmed\" id=\"18427125\" target=\"_blank\">",
"        18427125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8554 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-124.240.187.81-47114297B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41624=[""].join("\n");
var outline_f40_41_41624=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708918\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182136\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182137\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182180\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182141\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182158\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182142\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897618\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897619\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182116\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182101\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874618\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182120\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182176\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182188\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182178\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182123\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182105\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182174\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182110\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182132\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10949669\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182145\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10949670\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182125\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182113\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182117\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182126\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182104\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182122\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8554\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8554|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/18/36133?source=related_link\">",
"      Imipramine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/5/31831?source=related_link\">",
"      Imipramine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41625="Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents";
var content_f40_41_41625=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     Harland S Winter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/41/41625/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/41/41625/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux disease (GERD) is present when passage of gastric contents into the esophagus causes troublesome symptoms or complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. The range of symptoms and complications of GERD in children vary with age.",
"   </p>",
"   <p>",
"    This topic review focuses on the clinical manifestations and diagnosis of GERD in children and adolescents. The management of GERD in this age group and issues related to GERD in infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"     \"Gastroesophageal reflux in infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/6/23657?source=see_link\">",
"     \"Gastroesophageal reflux in premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These discussions are generally consistent with an official consensus statement and systematic review issued by the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. The full text of these guidelines is available at the NASPGHAN website (",
"    <a class=\"external\" href=\"file://www.naspghan.org/\">",
"     www.naspghan.org",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The passage of gastric contents into the esophagus (gastroesophageal reflux) is a normal physiologic process that occurs in healthy infants, children, and adults. Most episodes are brief and do not cause symptoms, esophageal injury, or other complications. In contrast, gastroesophageal reflux disease (GERD) is present when the reflux episodes are associated with troublesome symptoms or complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term \"regurgitate\" describes reflux to the oropharynx, and \"vomit\" describes expulsion of the refluxate out of the mouth, but not necessarily repetitively or with force. The terms are not clearly distinguished in clinical practice. In this review, we will use the term \"regurgitate\" to describe obvious gastroesophageal reflux, whether or not the refluxate is expelled from the mouth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few large population-based studies have described the epidemiology of GERD in children. Most studies focused on the prevalence of GERD in specific groups, such as infants with recurrent regurgitation. Comparison among studies is limited by the use of different definitions of GERD and the variable extent to which other possible causes of symptoms that were attributed to GERD were investigated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large community-based study documented prevalence rates of 1.8 to 8.2 percent for symptoms associated with gastroesophageal reflux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/2\">",
"     2",
"    </a>",
"    ]. Among adolescents, 3 to 5 percent complained of heartburn or epigastric pain, and 1 to 2 percent used antacids or acid-suppressing medication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regurgitation in infants is common and typically decreases or resolves during the first year of life. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"     \"Gastroesophageal reflux in infants\"",
"    </a>",
"    .) While the problem usually resolves by the end of infancy, there is a weak association with GERD later in life. As an example, frequent regurgitation during infancy and a history of GERD in the mother (but not the father) both predict the risk of reflux-related symptoms during childhood. This was demonstrated in a prospective cohort study in which children who had more than 90 days of frequent regurgitation during the first two years of life were more likely to have heartburn around nine years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms of GERD present during childhood are moderately likely to persist to adolescence and adulthood (\"tracking\"). In a survey of 207 patients who were diagnosed with GERD through an endoscopic examination in childhood (mean age 5 years), about one-third had symptoms of significant GERD during early adulthood (approximately 15 years later) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/4\">",
"     4",
"    </a>",
"    ]. At least 10 percent had weekly symptoms of reflux. Among those responding to the survey, 30 percent were currently taking acid suppressing medications, and 24 percent had undergone fundoplication. Other studies have shown similar results, but the lack of prospective trials limits the reliability of these observations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even less is known about the prevalence and natural history of GERD in older children and adolescents. However, the prevalence of GERD generally is considered to be much lower in adolescents than in adults. Exceptions are children with neuromuscular disorders such as muscular dystrophy and cerebral palsy and children with Down syndrome, who, for reasons that are poorly understood, are at increased risk for developing GERD and other esophageal motor abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Such children also appear to be at increased risk for developing respiratory complications related to GERD and represent a significant proportion of children referred for antireflux surgery. Complications of GERD, including esophageal adenocarcinoma, are more common in individuals who had repair of esophageal atresia in the perinatal period as compared to individuals without this congenital defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. GERD also appears to be relatively common in children with cystic fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/15/19706?source=see_link\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several other questions related to the epidemiology and natural history of GERD in children remain unanswered. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The healthcare burden related to its diagnosis and treatment, including effects on family members",
"     </li>",
"     <li>",
"      The impact on quality of life",
"     </li>",
"     <li>",
"      A detailed understanding about the relationship between reflux and the various extra-esophageal disease associations that have been hypothesized to be related to reflux (asthma, chronic cough, and recurrent pneumonia)",
"     </li>",
"     <li>",
"      The relationship between childhood GERD and the incidence of GERD and related complications in adulthood",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptoms of GERD vary according to age, although overlap may exist.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants &mdash; Gastroesophageal reflux is common in infants and is usually not pathological. Regurgitation is present in 50 to 70 percent of all infants, peaks at age 4 months, and typically resolves by 1 year. A small minority of infants with GERD develop other symptoms, including feeding refusal, irritability, hematemesis, anemia, respiratory symptoms, and failure to thrive. The clinical manifestations and management of gastroesophageal reflux in this age group is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"       \"Gastroesophageal reflux in infants\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Preschool &mdash; Preschool age children with GERD may present with intermittent regurgitation. Less commonly, they may have the respiratory complications including persistent wheezing. Decreased food intake without any other complaints may be a symptom of esophagitis in young children. All of these symptoms are nonspecific and insufficient to make a definitive diagnosis of GERD. Sandifer syndrome, an unusual posturing consisting of arching of the back, torsion of the neck, and lifting up of the chin, is fairly specific symptom of GERD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"       1",
"      </a>",
"      ]. It is most often found in preschool-aged children who are developmentally delayed, but may be seen in neuro-typical children as well. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8616?source=see_link&amp;anchor=H9#H9\">",
"       \"Acquired torticollis in children\", section on 'Sandifer syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Older children and adolescents &mdash; The pattern of symptoms and complications in older children and adolescents resembles that seen in adults. The cardinal symptoms are chronic heartburn",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      regurgitation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/11\">",
"       11",
"      </a>",
"      ]. Complications of GERD, including esophagitis, strictures, Barrett's esophagus, and hoarseness due to reflux laryngitis, also may be seen. Older children may complain of nausea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      epigastric pain, but many pre-adolescents will not localize pain and report diffuse abdominal discomfort. Some children may be observed pounding their chest. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1161?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/9/17561?source=see_link\">",
"       \"Approach to chronic cough in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      GERD-related chest pain is not well-described by young children. In older children, it typically is described as squeezing or burning, located substernally and sometimes radiating to the back, lasting anywhere from minutes to hours, and resolving either spontaneously or with antacids. It usually occurs after meals, awakens patients from sleep, and may be exacerbated by emotional stress.",
"      <br/>",
"      <br/>",
"      Extraesophageal associations with GERD also may be seen in older children and adolescents. In a large case-control study of children without neurologic defects, GERD was an independent risk factor for developing sinusitis (adjusted odds ratio [OR] 2.3), laryngitis (OR 2.6), asthma (OR 1.9), pneumonia (OR 2.3) and bronchiectasis (OR 2.3) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Asthma'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H22\">",
"       'Recurrent pneumonia'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of GERD in children is broad, particularly when the principal complaint is regurgitation, vomiting, or abdominal pain (",
"    <a class=\"graphic graphic_table graphicRef79114 \" href=\"mobipreview.htm?21/63/22526\">",
"     table 1",
"    </a>",
"    ). As a general rule, the diagnosis can be narrowed based upon the pattern of symptoms and the age of the child, supported by a thorough medical history (",
"    <a class=\"graphic graphic_table graphicRef61174 \" href=\"mobipreview.htm?18/18/18732\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Functional constipation is frequently associated with dyspeptic symptoms, including gastroesophageal reflux, heartburn, and nausea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In many cases, the constipation is unrecognized and the dyspeptic symptoms are the presenting complaint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/13\">",
"     13",
"    </a>",
"    ]. This probably occurs because the constipation delays gastric emptying via an intraintestinal reflex, termed the \"cologastric brake\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/14\">",
"     14",
"    </a>",
"    ]. Therefore, the child should be carefully evaluated for occult or recognized constipation; a rectal examination to determine if the rectal vault is packed with hard stool should be part of the evaluation. Effective treatment of the underlying constipation may relieve the dyspeptic symptoms and avoid invasive procedures or long-term pharmacotherapy for presumed GERD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=see_link\">",
"     \"Constipation in children: Etiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific testing should be guided by the type of symptoms and their severity. The following sections summarize characteristics of the available diagnostic tests. The utility of these tests will depend in large part on the age and clinical presentation of the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Empiric treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;An empiric trial of acid suppression is often used as a diagnostic test, and is suggested for children with uncomplicated heartburn [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. This is not a valuable diagnostic test in infants and young children, in whom symptoms of GERD are less specific. Studies in adults suggest that it may be a cost-effective approach in selected patients, although the applicability of these results to children is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=see_link\">",
"     \"Medical management of gastroesophageal reflux disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Endoscopy and histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic evaluation of the upper gastrointestinal tract is indicated for selected patients in whom esophagitis or gastritis is suspected. These include children or adolescents with heartburn, hematemesis, or epigastric abdominal pain that fails to respond to or relapses quickly after empiric treatment. In addition, endoscopy may be valuable in the evaluation of patients with recurrent regurgitation after two years of age, dysphagia, odynophagia, or a history of food impaction. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Suggested approach for common clinical scenarios'",
"    </a>",
"    below.) Upper airway symptoms such as hoarseness or stridor may also be caused by gastroesophageal reflux, but are usually evaluated with laryngoscopy rather than esophagoscopy.",
"   </p>",
"   <p>",
"    Unlike esophageal pH monitoring studies, endoscopy permits visualization of the esophageal epithelium as well as histologic evaluation, to determine the presence and severity of esophagitis and complications such as strictures or Barrett's esophagus, and to exclude other disorders such as eosinophilic esophagitis, allergic esophagitis, or infectious esophagitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1161?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An esophagus that appears normal at endoscopy does not exclude the presence of GERD. Sensitivity can be increased with mucosal biopsies, which may reveal intraepithelial eosinophils or other histologic findings consistent with GERD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Cellular injury stimulates cell proliferation, the morphologic equivalent of which is thickening of the basal cell layer and elongation of the papillae of the epithelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/16\">",
"     16",
"    </a>",
"    ]. Findings of basal zone hyperplasia are uncommon in young children, and other histologic features, such as the presence of neutrophils and eosinophils, and dilated vascular channels in papillae of the lamina propria are more typically seen in the pediatric population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/17\">",
"     17",
"    </a>",
"    ]. However, these histologic features are only moderately sensitive or specific for GERD, and if there are increased numbers of eosinophils, eosinophilic esophagitis should be considered; in children with histologic evidence of esophagitis, causes other than reflux should also be considered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The proportion of children with symptoms of GERD who have evidence of overt mucosal damage has not been well established. In one of the largest studies to address this issue, erosive esophagitis was described in 35 percent of 402 neurologically normal children (average age 9.7 years) who were referred for endoscopy due to GERD symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/19\">",
"     19",
"    </a>",
"    ]. Barrett's esophagus was uncommon.",
"   </p>",
"   <p>",
"    Endoscopy can be performed in infants, toddlers, and older children. Procedure-related complications of diagnostic endoscopy and biopsy appear to be rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/20\">",
"     20",
"    </a>",
"    ]. Complications may occur due to over- or under-sedation. In a series of 295 procedures performed in pediatric patients, complications included oxygen desaturation to less than 90 percent (n = 1), vital sign alterations requiring treatment (n = 3), rash (n = 2), dizziness (n = 1), wheezing (n = 1), and emergence reaction (an unexpected reaction when awakening from anesthesia, n = 1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/21\">",
"     21",
"    </a>",
"    ]. Another report focused on 393 patients (mean age 7.5 years, range 3 months to 21 years) who had undergone upper endoscopy under general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/22\">",
"     22",
"    </a>",
"    ]. The most common complications were sore throat or hoarseness, which occurred in 35 percent of patients.",
"   </p>",
"   <p>",
"    An infant or child with documented esophagitis should be treated with lifestyle changes and acid suppression therapy. Patients with only mild esophagitis can be assessed based upon the degree of symptom relief. Those with erosive esophagitis should undergo a repeat endoscopy to demonstrate healing. Treatment recommendations for these children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link&amp;anchor=H24#H24\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Esophagitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Eosinophilic (allergic) esophagitis is increasingly recognized in children and adults, and the symptoms and histological findings overlap with those of gastroesophageal reflux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The number and distribution of eosinophils can help distinguish GERD from eosinophilic esophagitis. Children with GERD tend to have more eosinophilic inflammation in the distal esophagus, whereas children with eosinophilic esophagitis may have more inflammation in the mid or proximal esophagus. In addition, many patients with eosinophilic esophagitis have a history of atopy or peripheral eosinophilia, and are more likely to fail to respond to anti-reflux treatment. Diagnostic and treatment approaches to these patients are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Esophageal pH monitoring or impedance monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal pH monitoring permits the assessment of the frequency and duration of esophageal acid exposure and its relationship to symptoms. However, the results do not correlate consistently with symptom severity or objective findings on endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. Therefore, pH monitoring can raise or lower suspicion of GERD, but is not a definitive diagnostic test, and is not useful in many clinical situations, especially in infants. In some children, distinguishing between GERD and eosinophilic esophagitis can be difficult. In this case, documentation of a normal intraesophageal pH monitoring or a trial of sustained acid suppression is needed before the diagnosis of eosinophilic esophagitis can be established. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The test is performed by the transnasal passage of a microelectrode containing a pH sensor into the lower esophagus. The pH electrode is positioned according to a formula that takes into account the length of the child. As a general rule, radiologic or manometric confirmation of the position of the tip of the probe is not necessary. A device worn by the patient records esophageal acid exposure during the period of monitoring. The procedure is considered to be very safe, but keeping the probe in place may be difficult in toddlers and uncooperative children. Newer devices that clip to the esophageal mucosa and remain in place for 24 hours allow recording of intraesophageal pH without the transnasal catheter. This technology can be used for older children and is particularly beneficial for children with autism in whom transnasal pH monitoring studies may be difficult to perform.",
"   </p>",
"   <p>",
"    The results of a pH probe study are influenced by the type of recording device, its exact position in the esophagus, diet, position of the patient, and activity during the study. Interpretation of results after longer periods of monitoring (24 hours) generally is more reliable than after shorter periods (eg, 12 hours), although longer periods of monitoring may not always be feasible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Episodes of acid reflux occur in asymptomatic infants, children, adolescents, and adults. The \"reflux index\" (the percentage of total time that the esophageal pH is less than 4) generally is considered to be the most valid measure of reflux because it provides an estimate of the cumulative esophageal acid exposure. In infants, a reflux index above 7 percent is considered abnormal, and between 3 and 7 percent is indeterminate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. Most studies in older children and adults use an upper limit between 4 and 7 percent for the reflux index. However, the correlation between the reflux index and clinical symptoms, disease or response to therapy is weak; results of esophageal pH monitoring should be interpreted in the context of other clinical information.",
"   </p>",
"   <p>",
"    In many centers, esophageal pH monitoring is combined with multichannel intraluminal impedance monitoring (MII) to allow measurement of weakly acidic and alkaline reflux episodes. In a trial comparing the two techniques, combined MII-pH monitoring detected associated symptoms twice as often as pH monitoring alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/29\">",
"     29",
"    </a>",
"    ]. Although pediatric standards for MII have not been established, the technique can still be helpful to determine whether there is a correlation between reflux episodes and certain symptoms. Impedance monitoring is discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26247?source=see_link\">",
"     \"Esophageal multichannel intraluminal impedance testing\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Uses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal pH monitoring or impedance monitoring can be useful in the following clinical situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1,30\">",
"     1,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical symptoms of reflux &mdash; In patients with laryngeal symptoms, severe or atypical asthma, or children who are nonverbal, esophageal pH monitoring can be useful to establish a temporal correlation between symptoms and episodes of reflux.",
"      <br/>",
"      <br/>",
"      Laryngeal symptoms that may be related to reflux include nocturnal stridor or cough. A dual-channel esophageal pH monitor, with electrodes in both distal and proximal esophagus, is particularly valuable for evaluating patients with these symptoms. However, no consensus exists on the pH criteria that should be used for defining pathologic reflux in this setting. One study suggested that a pH decrease of more than 2 pH units in the pharynx, occurring during esophageal acidification, and reaching a nadir of less than 4 units in less than 30 seconds was optimal for distinguishing patients with suspected regurgitation from healthy controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/31\">",
"       31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In patients with severe or atypical asthma, esophageal pH monitoring also can assess whether there is a temporal correlation between symptoms and reflux, particularly if asthmatic symptoms are discrete and positional. However, empiric trials of vigorous acid suppression also are used in this situation. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Asthma'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      In patients with recurrent pneumonia, it is difficult to establish whether esophageal reflux contributes to the problem. Abnormal results from esophageal pH monitoring are neither highly sensitive nor specific in detecting whether aspiration pneumonia is related to reflux, but patients with aspiration tend to reflux more frequently into the proximal esophagus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/30\">",
"       30",
"      </a>",
"      ]. Esophageal pH monitoring may help establish the diagnosis when combined with other investigations, including videofluoroscopic swallowing evaluation, bronchoscopy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endoscopy. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Recurrent pneumonia'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      In nonverbal children (eg, those with autism) behavioral changes or self-injurious behavior may be the only symptoms of GERD. Esophageal pH monitoring can support or help to exclude GERD as a cause of the behavioral symptoms.",
"     </li>",
"     <li>",
"      Reflux symptoms not responsive to medical or surgical therapy &mdash; Esophageal pH studies can determine the adequacy of acid suppression in children who remain symptomatic despite being treated with a proton pump inhibitor, or after surgical treatment for reflux. If the pH study shows adequate acid suppression, alternative explanations for the symptoms should be sought (eg, allergic esophagitis or alkaline reflux). If there is marked acid reflux, acid suppressive treatment should be optimized. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link&amp;anchor=H3#H3\">",
"       \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Pharmacotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with apnea or an apparent life-threatening event &mdash; If infants have repeated episodes of apnea, esophageal pH monitoring may be useful to determine if these are triggered by GERD. However, the association can be made only if performed simultaneously with polysomnography or oxycardiorespirography, and if an event occurs during monitoring. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"       \"Gastroesophageal reflux in infants\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=see_link\">",
"       \"Apparent life-threatening event in infants\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal pH monitoring does not detect anatomical abnormalities or directly measure the presence or severity of esophagitis, and does not provide information about reflux of nonacidic material from the stomach. Thus, it is NOT generally useful in the following clinical situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/11,30\">",
"     11,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of patients presenting with typical symptoms of reflux, heartburn or epigastric pain &mdash; Endoscopy and empiric trials of acid suppression will provide more definitive information about the clinical diagnosis and treatment options for these patients. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Heartburn'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients with esophagitis diagnosed by endoscopy &mdash; Abnormal reflux index correlates strongly with the presence of esophagitis on endoscopy (approximately 95 percent of children with esophagitis will have an abnormal reflux index) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/18,32\">",
"       18,32",
"      </a>",
"      ], but does not contribute to the diagnosis. Therefore, it is not a helpful investigation in patients with established esophagitis, except possibly to investigate reasons for inadequate response to therapy.",
"     </li>",
"     <li>",
"      Patients in whom alkaline reflux is suspected &mdash; In some patients, alkaline (rather than acid) reflux is suspected due to pyloric insufficiency or other abnormalities. In this case, standard esophageal pH monitoring is not helpful, but esophageal impedance-pH monitoring (or combined impedance and pH monitoring) may be beneficial in detecting neutral and alkaline reflux. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26247?source=see_link\">",
"       \"Esophageal multichannel intraluminal impedance testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with frequent regurgitation &mdash; In infants, esophageal pH monitoring is generally not useful to distinguish between infants with uncomplicated reflux and those with esophagitis or other pathological manifestations of GERD. Infants with failure to thrive or other symptoms suggesting pathological GERD require evaluation, but esophageal pH monitoring is rarely helpful in establishing the diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1,30\">",
"       1,30",
"      </a>",
"      ]. However, in infants with discrete episodes of irritability or other symptoms thought to be related to reflux, it may be used to establish whether there is a temporal relationship between occult reflux episodes and these discrete symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"       \"Gastroesophageal reflux in infants\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Barium contrast radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    studies of the esophagus are neither sensitive nor specific for the diagnosis of GERD. Compared to esophageal pH studies, the sensitivity, specificity, and positive predictive values have ranged from 31 to 86, 21 to 83, and 80 to 82 percent, respectively, in various reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/33-38\">",
"     33-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, radiologic evaluation is not useful to confirm or exclude GERD. However, it can be useful in the evaluation of selected patients with an atypical or severe presenting features, particularly those with dysphagia or odynophagia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. In such patients, the contrast study is used to evaluate for the possibility of anatomic abnormalities, including hiatal hernia, achalasia, tracheoesophageal fistula, anastomotic strictures, antral web, intestinal malrotation, or peptic strictures. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Dysphagia or odynophagia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bronchoalveolar lavage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoscopy with bronchoalveolar lavage is occasionally used to assess for evidence of recurrent small-volume aspiration. If aspirates contain a high percentage of lipid-laden macrophages, aspiration is thought to be more likely. However, this technique has low sensitivity and specificity. Even with careful measurement protocols, there is considerable overlap in findings between patients with aspiration and normal controls, so the technique is not generally useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1,39\">",
"     1,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nuclear scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nuclear scintigraphy involves the ingestion of technetium-labeled food or formula followed by scanning to detect the distribution of the isotope in the stomach, esophagus, and lungs. Potential advantages compared to esophageal pH monitoring are the ability to demonstrate the reflux of nonacidic gastric contents and assessment of the rate of gastric emptying. However, its sensitivity for the detection of acid reflux was poor when compared to esophageal pH monitoring (sensitivity 15 to 59 percent) whereas its specificity ranged from 83 to 100 percent in various reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/34,40,41\">",
"     34,40,41",
"    </a>",
"    ]. As a result, scintigraphy has a limited role in the diagnosis and management of GERD in children.",
"   </p>",
"   <p>",
"    In selected patients who experience recurrent aspiration, a salivagram may be helpful in determining whether the aspiration is caused by swallowing problems or whether it is related to gastroesophageal reflux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=see_link&amp;anchor=H367105430#H367105430\">",
"     \"Aspiration due to swallowing dysfunction in infants and children\", section on 'Gastroesophageal scintigraphy and salivagram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Esophageal manometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal manometry is of minimal use in the diagnosis of typical GERD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. One possible exception is for the evaluation of peristaltic function before antireflux surgery to exclude major motor disorders and to assess esophageal motility in children with dysphagia in whom a primary motility disorder, such as achalasia, is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    .) The American Gastroenterological Association (AGA) guideline for esophageal manometry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/43\">",
"     43",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA Web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     file://www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUGGESTED APPROACH FOR COMMON CLINICAL SCENARIOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The previous discussion underscores the variable presentation of GERD in infants and children and the need to modify the diagnostic approach based upon the patient's age, type of symptoms, and their severity. The following sections will provide general recommendations for diagnosis in infants and children with commonly seen clinical presentations. These recommendations are based upon a guideline issued by NASPGHAN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Recurrent vomiting or regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otherwise healthy children with recurrent vomiting or regurgitation after reaching the age of 18 months usually require evaluation, which typically includes an upper gastrointestinal series to look for anatomic abnormalities, evaluation of metabolic disorders, or consideration of neurologic problems. An upper endoscopy with biopsy may be helpful in determining if the child has mucosal inflammation related to a food protein intolerance. If the evaluation reveals no abnormalities, and the child is otherwise asymptomatic and thriving, further workup may not be required at this time. However, a two-week trial of acid suppression treatment may be considered if there is reason to believe that it will improve the child's quality of life. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Prokinetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Heartburn",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children or adolescents with heartburn can be treated empirically with lifestyle changes and an empiric trial of acid suppression. Persistent or recurrent symptoms, should prompt referral for an upper endoscopy with biopsy, especially if any dysphagia is present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link&amp;anchor=H23#H23\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Heartburn'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Dysphagia or odynophagia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysphagia is a sensation of difficulty swallowing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients' complaints range from the inability to initiate a swallow to the sensation of solids or liquids being hindered during their passage through the esophagus into the stomach. Dysphagia for solids is most commonly associated with mucosal inflammation related to peptic injury, eosinophilic esophagitis, or esophageal stricture. Dysphagia for liquids raises the possibility of a motility disorder such as achalasia.",
"   </p>",
"   <p>",
"    The term \"odynophagia\" refers to pain with swallowing, and is more commonly seen in patients with esophagitis caused by candida, cytomegalovirus or herpes. An adolescent with acute onset of heartburn or odynophagia should be questioned about the use of drugs that may cause pill esophagitis, including tetracyclines (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/20/43334?source=see_link\">",
"     minocycline",
"    </a>",
"    ) that are commonly used for treatment of acne. Therefore, further evaluation is indicated for patients presenting with these symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. An upper endoscopy should be considered prior to initiating empiric treatment with a proton pump inhibitor (PPI) for odynophagia, because acid suppression may not be beneficial if an infection is present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37078?source=see_link\">",
"     \"Medication-induced esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a stricture is suspected, children with dysphagia or odynophagia should undergo a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophagram which will establish the location of a narrowing, and also identify other anatomic abnormalities, including achalasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/26/14759?source=see_link\">",
"     \"Clinical manifestations and diagnosis of achalasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Empiric treatment is not recommended, because an upper endoscopy is necessary to identify the cause of the dysphagia or odynophagia and guide specific treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux may be a trigger for asthma in some patients. Abnormal reflux, as measured by symptoms or by esophageal pH monitoring, occurs in 25 to 75 percent of children with persistent asthma, and the association increases with severity of either condition, but the clinical significance of this association is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Many studies have shown clinical improvement in asthma when patients are treated for reflux [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/44,46\">",
"     44,46",
"    </a>",
"    ]. However, predicting which patients are likely to respond to treatment remains problematic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1,47\">",
"     1,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with asthma and symptoms suggesting GERD (including heartburn in older children and adolescents, or chronic vomiting or regurgitation) should undergo a three-month trial of appropriate acid suppression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link&amp;anchor=H26#H26\">",
"     \"Management of gastroesophageal reflux disease in children and adolescents\", section on 'Asthma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gastroesophageal reflux may trigger asthma in some patients even in the absence of symptoms of GERD. Therefore, esophageal pH monitoring or an empiric three-month trial of vigorous acid suppression is recommended by many experts for patients with either of the following characteristics, particularly if they lack seasonal or allergic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1,44\">",
"     1,44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nocturnal asthma more than once a week",
"     </li>",
"     <li>",
"      Continuous need for oral corticosteroids, high-dose inhaled corticosteroids, more than two bursts per year of oral corticosteroids, or persistent asthma that does not allow the patient to be weaned from medical management",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar approaches are used for adult patients with asthma and possible GERD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39816?source=see_link\">",
"     \"Gastroesophageal reflux and asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Recurrent pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;GERD can be associated with recurrent pneumonia even in the absence of esophagitis or abnormal findings on esophageal pH studies. Data are insufficient to provide firm recommendations on the approach to such patients. In addition to excluding other causes of recurrent pneumonia (such as a foreign body, cystic fibrosis, or immunodeficiency), evaluation may include bronchoscopy and nuclear scintigraphy. However, neither of these tests provides definitive evidence that GERD is the cause of the recurrent pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Recurrent pneumonia is more likely to be caused by inadequate airway protective mechanisms during swallowing. Therefore, it is also important to assess these mechanisms using videofluoroscopy before embarking on invasive treatments for GERD, particularly in children with known neurologic dysfunction. An H-type tracheo-esophageal fistula should also be considered in a child with recurrent pneumonia, especially if the same segment of the lung is always involved. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=see_link\">",
"     \"Aspiration due to swallowing dysfunction in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=see_link&amp;anchor=H16#H16\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheoesophageal fistula and esophageal atresia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Chronic cough",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most authorities suggest that GERD is not a common cause of isolated chronic cough in children except in association with neurologic abnormalities predisposing to aspiration. Children with chronic cough should be evaluated for a variety of other causes, including asthma (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28088?source=see_link&amp;anchor=H9#H9\">",
"     \"Causes of chronic cough in children\", section on 'Gastroesophageal reflux'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/9/17561?source=see_link\">",
"     \"Approach to chronic cough in children\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/11/40114?source=see_link\">",
"       \"Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/50/32547?source=see_link\">",
"       \"Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/16/16643?source=see_link\">",
"       \"Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastroesophageal reflux is common in infants, as manifested by regurgitation, and is generally not pathological. The regurgitation usually resolves by 18 months of age.",
"     </li>",
"     <li>",
"      Symptoms suggestive of pathological gastroesophageal reflux, or gastroesophageal reflux disease (GERD) include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Recurrent regurgitation after two years of age",
"     </li>",
"     <li>",
"      Refusal of food, especially solids",
"     </li>",
"     <li>",
"      Hematemesis",
"     </li>",
"     <li>",
"      Frequent complaints of heartburn",
"     </li>",
"     <li>",
"      Severe or progressive asthma",
"     </li>",
"     <li>",
"      Recurrent pneumonia, particularly in children with neurologic dysfunction",
"     </li>",
"     <li>",
"      Chronic hoarseness or stridor",
"     </li>",
"     <li>",
"      Dysphagia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When children present with these symptoms, further workup is appropriate. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Suggested approach for common clinical scenarios'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation should include assessment for the possibility of occult or associated constipation, since constipation causes secondary dyspeptic symptoms in many children. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=see_link\">",
"       \"Constipation in children: Etiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients presenting with mild or moderate symptoms of heartburn, empiric treatment with acid suppressing drugs is reasonable. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Empiric treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endoscopic evaluation of the upper gastrointestinal tract is indicated for patients with heartburn or epigastric abdominal pain that fails to respond to or relapses quickly after empiric treatment. In addition, it may be valuable in the evaluation of patients who continue to have recurrent regurgitation after two years of age, or in those with dysphagia or odynophagia. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Suggested approach for common clinical scenarios'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Endoscopy and histology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endoscopic evaluation is necessary to establish the diagnosis of esophagitis. Most esophagitis is related to acid reflux, but eosinophilic esophagitis is increasingly recognized. Treatment of esophagitis is discussed separately. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Endoscopy and histology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=see_link\">",
"       \"Management of gastroesophageal reflux disease in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation with esophageal pH monitoring,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      contrast radiography, bronchoalveolar lavage, nuclear scintigraphy, or esophageal manometry is only valuable in specific clinical situations, and does not generally contribute to the diagnosis of a child with typical heartburn. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In some patients, gastroesophageal reflux may be a trigger for asthma. Therefore, in patients with severe or refractory asthma, an empiric trial of effective acid suppression is appropriate. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Asthma'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39816?source=see_link\">",
"       \"Gastroesophageal reflux and asthma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children with dysphagia should have a",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      esophagram to evaluate for motility disorders and anatomic causes of the symptoms; upper endoscopy may also be helpful in diagnosing esophagitis. Empiric treatment with acid suppression is not recommended especially in children with odynophagia who may have an infectious esophagitis. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Dysphagia or odynophagia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/1\">",
"      Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/2\">",
"      Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 2000; 154:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/3\">",
"      Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002; 109:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/4\">",
"      El-Serag HB, Gilger M, Carter J, et al. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol 2004; 99:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/5\">",
"      El-Serag HB, Richardson P, Pilgrim P, Gilger MA. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2007; 5:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/6\">",
"      Z&aacute;rate N, Mearin F, Hidalgo A, Malagelada JR. Prospective evaluation of esophageal motor dysfunction in Down's syndrome. Am J Gastroenterol 2001; 96:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/7\">",
"      Hillemeier C, Buchin PJ, Gryboski J. Esophageal dysfunction in Down's syndrome. J Pediatr Gastroenterol Nutr 1982; 1:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/8\">",
"      Orleans CT. Context, confidentiality, and consent in tailored health communications: a cautionary note. Ann Behav Med 1999; 21:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/9\">",
"      Sistonen SJ, Koivusalo A, Nieminen U, et al. Esophageal morbidity and function in adults with repaired esophageal atresia with tracheoesophageal fistula: a population-based long-term follow-up. Ann Surg 2010; 251:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/10\">",
"      Adzick NS, Fisher JH, Winter HS, et al. Esophageal adenocarcinoma 20 years after esophageal atresia repair. J Pediatr Surg 1989; 24:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/11\">",
"      Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009; 104:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/12\">",
"      El-Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology 2001; 121:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/13\">",
"      Borowitz SM, Sutphen JL. Recurrent vomiting and persistent gastroesophageal reflux caused by unrecognized constipation. Clin Pediatr (Phila) 2004; 43:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/14\">",
"      Boccia G, Buonavolont&agrave; R, Coccorullo P, et al. Dyspeptic symptoms in children: the result of a constipation-induced cologastric brake? Clin Gastroenterol Hepatol 2008; 6:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/15\">",
"      Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999; 159:2161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/16\">",
"      Orlando RC. Esophageal epithelial defenses against acid injury. Am J Gastroenterol 1994; 89:S48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/17\">",
"      Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/18\">",
"      Black DD, Haggitt RC, Orenstein SR, Whitington PF. Esophagitis in infants. Morphometric histological diagnosis and correlation with measures of gastroesophageal reflux. Gastroenterology 1990; 98:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/19\">",
"      El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol 2002; 97:1635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/20\">",
"      Rothbaum RJ. Complications of pediatric endoscopy. Gastrointest Endosc Clin N Am 1996; 6:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/21\">",
"      Slonim AD, Ognibene FP. Sedation for pediatric procedures, using ketamine and midazolam, in a primarily adult intensive care unit: a retrospective evaluation. Crit Care Med 1998; 26:1900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/22\">",
"      Samer Ammar M, Pfefferkorn MD, Croffie JM, et al. Complications after outpatient upper GI endoscopy in children: 30-day follow-up. Am J Gastroenterol 2003; 98:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/23\">",
"      Ngo P, Furuta GT. Treatment of eosinophilic esophagitis in children. Curr Treat Options Gastroenterol 2005; 8:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/24\">",
"      Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006; 101:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/25\">",
"      Mahajan L, Wyllie R, Oliva L, et al. Reproducibility of 24-hour intraesophageal pH monitoring in pediatric patients. Pediatrics 1998; 101:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/26\">",
"      Vandenplas Y, Helven R, Goyvaerts H, Sacr&eacute; L. Reproducibility of continuous 24 hour oesophageal pH monitoring in infants and children. Gut 1990; 31:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/27\">",
"      Friesen CA, Hodge C, Roberts CC. Accuracy and reproducibility of 12-h esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1991; 12:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/28\">",
"      Barabino A, Costantini M, Ciccone MO, et al. Reliability of short-term esophageal pH monitoring versus 24-hour study. J Pediatr Gastroenterol Nutr 1995; 21:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/29\">",
"      Salvatore S, Arrigo S, Luini C, Vandenplas Y. Esophageal impedance in children: symptom-based results. J Pediatr 2010; 157:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/30\">",
"      Colletti RB, Christie DL, Orenstein SR. Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1995; 21:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/31\">",
"      Cucchiara S, Santamaria F, Minella R, et al. Simultaneous prolonged recordings of proximal and distal intraesophageal pH in children with gastroesophageal reflux disease and respiratory symptoms. Am J Gastroenterol 1995; 90:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/32\">",
"      Cucchiara S, Staiano A, Gobio Casali L, et al. Value of the 24 hour intraoesophageal pH monitoring in children. Gut 1990; 31:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/33\">",
"      Stephen TC, Younoszai MK, Massey MP, Fellows RA. Diagnosis of gastroesophageal reflux in pediatrics. J Ky Med Assoc 1994; 92:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/34\">",
"      Seibert JJ, Byrne WJ, Euler AR, et al. Gastroesophageal reflux--the acid test: scintigraphy or the pH probe? AJR Am J Roentgenol 1983; 140:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/35\">",
"      Meyers WF, Roberts CC, Johnson DG, Herbst JJ. Value of tests for evaluation of gastroesophageal reflux in children. J Pediatr Surg 1985; 20:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/36\">",
"      Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. AJR Am J Roentgenol 1994; 162:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/37\">",
"      Gupta JP, Kumar A, Jain AK, et al. Gastro-esophageal reflux disease (GERD): an appraisal of different tests for diagnosis. J Assoc Physicians India 1990; 38 Suppl 1:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/38\">",
"      Chen MY, Ott DJ, Sinclair JW, et al. Gastroesophageal reflux disease: correlation of esophageal pH testing and radiographic findings. Radiology 1992; 185:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/39\">",
"      Rosen R, Fritz J, Nurko A, et al. Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Pediatrics 2008; 121:e879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/40\">",
"      Arasu TS, Wyllie R, Fitzgerald JF, et al. Gastroesophageal reflux in infants and children comparative accuracy of diagnostic methods. J Pediatr 1980; 96:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/41\">",
"      Tolia V, Kauffman RE. Comparison of evaluation of gastroesophageal reflux in infants using different feedings during intraesophageal pH monitoring. J Pediatr Gastroenterol Nutr 1990; 10:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/42\">",
"      Simons JP, Rubinstein EN, Mandell DL. Clinical predictors of aspiration on radionuclide salivagrams in children. Arch Otolaryngol Head Neck Surg 2008; 134:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/43\">",
"      Pandolfino JE, Kahrilas PJ, American Gastroenterological Association. American Gastroenterological Association medical position statement: Clinical use of esophageal manometry. Gastroenterology 2005; 128:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/44\">",
"      Gold BD. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr 2005; 146:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/45\">",
"      Thakkar K, Boatright RO, Gilger MA, El-Serag HB. Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics 2010; 125:e925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/46\">",
"      Khoshoo V, Le T, Haydel RM Jr, et al. Role of gastroesophageal reflux in older children with persistent asthma. Chest 2003; 123:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/41/41625/abstract/47\">",
"      Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003; :CD001496.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5892 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-5368725AE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41625=[""].join("\n");
var outline_f40_41_41625=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Empiric treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Endoscopy and histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Esophageal pH monitoring or impedance monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Uses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Barium contrast radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bronchoalveolar lavage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nuclear scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Esophageal manometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUGGESTED APPROACH FOR COMMON CLINICAL SCENARIOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Recurrent vomiting or regurgitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Heartburn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Dysphagia or odynophagia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Recurrent pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Chronic cough",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5892\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5892|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/63/22526\" title=\"table 1\">",
"      DDx vomiting children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/18/18732\" title=\"table 2\">",
"      Hx GERD child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8616?source=related_link\">",
"      Acquired torticollis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/34/31272?source=related_link\">",
"      Apparent life-threatening event in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/9/17561?source=related_link\">",
"      Approach to chronic cough in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=related_link\">",
"      Aspiration due to swallowing dysfunction in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28088?source=related_link\">",
"      Causes of chronic cough in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/26/14759?source=related_link\">",
"      Clinical manifestations and diagnosis of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/63/15354?source=related_link\">",
"      Constipation in children: Etiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1161?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/40/26247?source=related_link\">",
"      Esophageal multichannel intraluminal impedance testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39816?source=related_link\">",
"      Gastroesophageal reflux and asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=related_link\">",
"      Gastroesophageal reflux in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/6/23657?source=related_link\">",
"      Gastroesophageal reflux in premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/33/19994?source=related_link\">",
"      Management of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37078?source=related_link\">",
"      Medication-induced esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/50/32547?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/11/40114?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/16/16643?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux) in infants (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_41_41626="Inverse psoriasis";
var content_f40_41_41626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79274%7EDERM%2F76200%7EDERM%2F78531%7EDERM%2F50615%7EDERM%2F62411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79274%7EDERM%2F76200%7EDERM%2F78531%7EDERM%2F50615%7EDERM%2F62411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 217px; height: 145px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inverse psoriasis of the axilla (armpit) is characterized by erythema without visible scaling.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James C Shaw, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous plaques involve the inguinal area in this patient with inverse psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined erythematous plaque is present in the inframammary area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, fissured plaque is present on the intergluteal skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inverse psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous plaque is present on the intergluteal skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41626=[""].join("\n");
var outline_f40_41_41626=null;
var title_f40_41_41627="Signs of autism";
var content_f40_41_41627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Signs of autism spectrum disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        A child with an ASD might:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Not play \"pretend\" games (pretend to feed a doll)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Not point at objects to show interest (point at an airplane flying over)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Not look at objects when another person points at them",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have trouble relating to others or not have an interest in other people at all",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid eye contact and want to be alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prefer not to be held or cuddled or might cuddle only when they want to",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appear to be unaware when other people talk to them but respond to other sounds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Be very interested in people, but not know how to talk to, play with, or relate to them",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat or echo words or phrases said to them, or repeat words or phrases in place of normal language (echolalia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have trouble expressing their needs using typical words or motions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Repeat actions over and over again",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have trouble adapting when a routine changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have unusual reactions to the way things smell, taste, look, feel, or sound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lose skills they once had (for instance, stop saying words they were once using)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and Prevention. National Center on Birth Defects and Developmental Disabilities. \"Learn the signs. Act early.\" campaign. Available at: www.cdc.gov/ncbddd/autism/actearly/autism.html.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41627=[""].join("\n");
var outline_f40_41_41627=null;
var title_f40_41_41628="Asthma severity 0 to 4 yrs";
var content_f40_41_41628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classifying asthma severity in children 0-4 years of age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"3\">",
"        Components of severity",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Classification of asthma severity (children 0-4 years of age)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" rowspan=\"2\">",
"        Intermittent",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"4\">",
"        Persistent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Mild",
"       </td>",
"       <td class=\"subtitle3\">",
"        Moderate",
"       </td>",
"       <td class=\"subtitle3\">",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Impairment",
"       </td>",
"       <td>",
"        Symptoms",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week but not daily",
"       </td>",
"       <td>",
"        Daily",
"       </td>",
"       <td>",
"        Throughout the day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nighttime awakenings",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        1-2x/month",
"       </td>",
"       <td>",
"        3-4x/month",
"       </td>",
"       <td>",
"        &gt;1x/week",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Short-acting beta",
"        <sub>",
"         2",
"        </sub>",
"        -agonist use for symptom control (not prevention of EIB)",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week but not daily",
"       </td>",
"       <td>",
"        Daily",
"       </td>",
"       <td>",
"        Several times per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interference with normal activity",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Minor limitation",
"       </td>",
"       <td>",
"        Some limitation",
"       </td>",
"       <td>",
"        Extremely limited",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Risk",
"       </td>",
"       <td rowspan=\"4\">",
"        <strong>",
"         Exacerbations requiring oral systemic corticosteroids",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         0-1/year",
"        </strong>",
"       </td>",
"       <td colspan=\"3\">",
"        <strong>",
"         &ge;2 exacerbations in 6 months requiring oral steroids, or &ge;4 wheezing episodes/1 year lasting &gt;1 day AND risk factors for persistent asthma",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Consider severity and interval since last exacerbation",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Frequency and severity may fluctuate over time",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Exacerbations of any severity may occur in patients in any severity category",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Classifying severity in children who are not currently taking long-term control medication.",
"    </strong>",
"    Level of severity is determined by both impairment and risk. Assess impairment domain by caregiver's recall of previous 2-4 weeks. Assign severity to the most severe category in which any feature occurs. At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma severity. For treatment purposes, patients who had &ge;2 exacerbations requiring oral corticosteroids in the past 6 months, or &ge;4 wheezing episodes in the past year, and who have risk factors for persistent asthma may be considered the same as patients who have persistent asthma, even in the absence of impairment levels consistent with persistent asthma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41628=[""].join("\n");
var outline_f40_41_41628=null;
var title_f40_41_41629="CT-based algorithm for PE";
var content_f40_41_41629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    CT-based diagnostic strategy used in patients with suspected pulmonary embolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from van Belle, A, et al. JAMA 2006; 295:172.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41629=[""].join("\n");
var outline_f40_41_41629=null;
var title_f40_41_41630="Alcohol intake stroke risk";
var content_f40_41_41630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56342&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56342&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light alcohol consumption reduces the risk of stroke",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 547px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The relationship between stroke of various etiologies and alcohol consumption was evaluated in 26,556 male cigarette smokers; relative risks were adjusted for age, body mass index, serum total cholesterol, number of cigarettes smoked daily, history of diabetes, history of heart disease, education, leisure-time activity, and supplementation with an antioxidant. Systolic blood pressure (SBP) and HDL cholesterol (HDLC) were added separately. Light alcohol intake reduced the risk of a stroke, while moderate and heavy consumption increased the risk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Leppala, JM, Paunio, M, Virtamo, J, et al, Circulation 1999; 100:1209.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41630=[""].join("\n");
var outline_f40_41_41630=null;
var title_f40_41_41631="Amplatzer ductal occluder";
var content_f40_41_41631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The Amplatzer Ductal Occluder device",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Hill, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_41_41631=[""].join("\n");
var outline_f40_41_41631=null;
